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ABSTRACT OF THE PROPOSAL

The Effect of Non-Exercise Activity Thermogenesis on Subjects
with Metabolic Syndrome
by
Samer Hammoudeh
Doctor of Public Health Candidate in Preventive Care
School of Public Health, Loma Linda University, 2012
Dr. Serena Tonstad, Chair

Metabolic syndrome is a cluster of metabolic abnormalities that increases the risk
of cardiovascular disease and type 2 diabetes. Several criteria establish the diagnosis of
metabolic syndrome, including high waist circumference, low HDL cholesterol, high
triglycerides and glucose and above normal blood pressure. The prevalence of metabolic
syndrome is on the rise following the rise in obesity across the globe. Qatar, a country in
the Arabian Peninsula shares the burden of obesity with recent studies showing
prevalences of'---61% among women and —39% among men. These studies found that
metabolic syndrome is more common among women. Physical activity helps reduce
visceral obesity, controls glucose levels, and improves blood pressure, triglyceride, and
HDL cholesterol levels. One way of increasing physical activity is by promoting nonexercise activity thermogenesis (NEAT). NEAT represents 10% of daily human energy
expenditure and is expended during daily life activities like mowing the lawn or climbing
stairs. A lifestyle intervention study was conducted with 200 Qatari subjects identified
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with metabolic syndrome. The study was approved by the research committee at Hamad
Medical Hospital in Doha, Qatar. The study aimed to reduce the number of components
of metabolic syndrome in men and women with metabolic syndrome treated at the
diabetes and endocrinology department by promoting increased NEAT. In a randomized
clinical trial lasting one year the intervention group received general exercise and dietary
guidelines in addition to information on how to increase their daily NEAT, while the
control group received solely the general exercise and dietary guidelines. Subjects in the
intervention group were asked to incorporate NEAT by modifying their work
environment, and daily habits such as going shopping, standing instead of sitting, and
walking instead of using the car. Text message reminders were sent to the intervention
group at two, four, eight, and 10 months. Body weight, waist circumference as a measure
of visceral obesity, blood pressure, glucose level and lipid profile were assessed at
baseline, 6 months, and 1 year in both groups. Archival data obtained through this study
were analyzed after gaining permission from the Loma Linda University Institutional
Review Board. After 1 year 52 intervention and 55 control subjects completed the study.
The results revealed no statistically significant differences in metabolic syndrome
components between the two randomized groups. Additionally analysis of subgroups
including those on anti-diabetic medication versus those not taking such medication
revealed no differences between the intervention and control groups. The amount of
recommended NEAT activity appears to have been too small to influence study
outcomes. Future studies in similar populations may need to consider the high dropout
rate, and use of incentives or culturally appropriate interventions to increase compliance
and retention.
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CHAPTER 1
INTRODUCTION

A. Statement of the Problem
1. High Prevalence of Metabolic Syndrome
Metabolic syndrome is a combination of several abnormalities that
increase the risk of cardiovascular disease (CVD). Each abnormality is associated with
cardiovascular disease cases (Bener et al., 2009), such as stroke, myocardial infarction,
and heart failure (Musallam et al., 2008). These abnormalities may include, but are not
limited to the following items, high blood pressure (hypertension), elevated levels of
fasting glucose, insulin resistance (Bener et al., 2009), obesity, especially central obesity
characterized by accumulation of fat in the abdomen, dyslipidemia characterized by low
levels of HDL cholesterol, also known as "good cholesterol", and high levels of
triglycerides (Meigs, 2003). The constellation of the above items increases the risk of
developing diabetes, or impaired fasting glucose (Bener et al., 2009), and ultimately
increases the risk of premature mortality (International Diabetes Federation (IDF), 2006).
Meigs (2004) reports that obese patients with metabolic syndrome have a 10 fold
increased risk of developing diabetes and a twofold increased risk for CVD, in
comparison to individuals with normal weight and without metabolic syndrome. Meigs
recommends aggressive lifestyle intervention in order to reduce the associated risk.
Grundy et al. (2005) indicate that the primary goal in the clinical management of patients
with this syndrome is focused around reducing risk of atherosclerosis by modifying risk
factors like obesity, physical inactivity, and diet which may occur through appropriate
lifestyle changes.

Metabolic syndrome can be identified according to different criteria. For the
National Cholesterol Education Program/Adult Treatment Panel III criteria, the person
must have three or more of the following five abnormalities; (a) Fasting plasma glucose
over or equal to 100 mg/dL (5.6 mmol/L), or drug treatment for elevated blood glucose;
(b) HDL cholesterol less than 40 mg/dL (1.0 rnmol/L) for men, and 50 mg/dL
(1.3 mmol/L) for women, or treatment for low HDL cholesterol; (c) Triglycerides over or
equal to 150 mg/dL (1.7 mmol/L), or treatment for elevated triglycerides; (d) High blood
pressure over or equal to 130/85 mmHg, or treatment for hypertension; (e) Obesity
characterized by a waist circumference over or equal to 102 cm (40.15 inch) for men, and
over or equal to 88 cm (34.64 inch) for women (Meil.2.,,s, 2004).
For the International Diabetes Federation, central obesity is the primary criteria
with different cutoff scores for different ethnicities, with elevated waist circumference of
over or equal to 94 cm for men, and 80 cm for women. Additionally, the patient must
have two or more abnormalities out of four of the following: (a) Fasting plasma glucose
over or equal to 100 mg/dL (5.6 mmol/L), or diagnosed type 2 diabetes; (b) High blood
pressure over or equal to 130/85 mmHg, or treatment for hypertension; (c) Triglycerides
over or equal to 150 mg/dL (1.7 mmol/L), or treatment for elevated triglycerides;
(d) HDL cholesterol less than 40 mg/dL (1.0 mmol/L) for men, and 50mg/dL
(1.3 mmol/L) for women, or treatment for low HDL cholesterol (IDF, 2006).
In order to have a single definition, several organizations, including the above
two, agreed on a harmonized definition in 2009. For the harmonized definition of
metabolic syndrome, the person must have three or more of the following five
abnormalities; (a) Elevated waist circumference which is population and country specific;

(b) Elevated triglycerides over or equal to 150 mg/dL (1.7 mmol/L), or drug treatment for
elevated triglycerides; (c) Reduced HDL cholesterol less than 40 mg/dL for males and
less than 50 mg/dL for females, or drug treatment for reduced HDL cholesterol;
(d) Elevated blood pressure over or equal to 130 mm Hg for systolic and/or over or equal
to 85 mm Hg for diastolic, or drug treatment for hypertension; (e) Elevated fasting
glucose above or equal to 100 mg/dL, or drug treatment for elevated glucose (Alberti
et al., 2009).
Worldwide, approximately 25% of the population suffers the burden of symptoms
related to metabolic syndrome. Novak and Levine (2007), report that approximately one
billion people worldwide are overweight or obese. After conducting a thorough literature
review on metabolic syndrome in the Middle East, no comprehensive peer reviewed
literature studies were found to provide accurate numbers of the prevalence in the area in
general. Most studies focus on specific countries, such as Iran and Emirates. Both of
these studies showed increased prevalence of metabolic syndrome among their
populations. The burden is shared among the Qatari population, which suffer from high
prevalence rates of obesity and type 2 diabetes. The metabolic syndrome prevalence rates
in this population are about 26.4% according to the Adult Treatment Panel III (ATP)
criteria, and 34% according to the International Diabetes Federation (IDF) criteria
(Musallam et al., 2008). In regard to gender, females had higher prevalence rates.
According to the ATP criteria the prevalences are 56.3% for females, and 43.3% for
males with higher rates using IDF criteria (Bener et al., 2009).
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2.• Metabolic Syndrome Risk Factors
Some of the common risk factors include age, menopause, race, sex
hormone disturbances, hyperandrogenism in pre and post menopausal women, high
caloric intake, physical inactivity, family history, obstructive sleep apnea syndrome, and
psychosocial and personality factors (Fan, 2007). The risk for metabolic syndrome
increases with age; reports show that metabolic syndrome affects about 10% of those in
their twenties in comparison to 40% of those that are in their sixties, while signs and
symptoms can appear as early as childhood. For type 2 diabetes, risk is increased in
people with a family history of type 2 diabetes, or with gestational diabetes during
pregnancy. In regard to race, some ethnicities seem to have higher risk of developing this
syndrome, such as Hispanics or Middle Easterners. For obesity, a body mass index (BMI)
above 25 increases the risk of developing the metabolic syndrome. Abdominal obesity
increases the risk; due to the effects of visceral fat accumulation and its several clinical
implications which are discussed in more detail later (Mayo Clinic, 2009).
Risk factors associated with metabolic syndrome in the Qatari population include
age, ethnicity, obesity and family history of diabetes (Musallam et al., 2008). Musallam
et al.'s study showed that abdominal obesity is the most common metabolic syndrome
abnormality in the Qatari population. The authors attribute this to the general economic
growth witnessed in that geographic area, for example increased levels of urbanization
and lifestyle leading to increases in diabetes mellitus. Additionally, the hot weather
environment seems to be a factor that limits physical activity. In regard to age, the study
showed a nine fold increase in age specific prevalence of metabolic syndrome for the age
group 20-30, who had a prevalence rate of 7.9%, and to above 60 years of age, a group
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that had a prevalence rate of 70.3%. As for gender, women had higher prevalence rates
than men, as 61.4% in comparison to 38.6% in men. The authors attribute this partially to
cultural factors that restrict women engagement in outdoor activities. More individuals
with family history of diabetes had metabolic syndrome in comparison to those not
having a family history of diabetes in this population.
3. Metabolic Syndrome Etiology
Factors that play an important role in the development of this condition
include genetics, sedentary lifestyle, cigarette smoking, progressive weight gain, and a
Western diet high in carbohydrates, saturated fat, and low in fiber (Pitsavos et al., 2007;
Schiltz et al., 2009). As for diet, an atherogenic one, which is rich in saturated fat and
cholesterol, may increase the risk of developing CVD in individuals with metabolic
syndrome, although it is not listed as a risk factor for the syndrome (Grundy et al., 2005).
It is clear that excess consumption of energy, regardless of the macronutrient
composition, is associated with visceral accumulation of excess fat (Levine, 2007).
Meigs (2002) reports that certain genes may contribute to metabolic syndrome, as
family studies show that specific metabolic risk factors may be transmitted from the
parents to the offspring. These studies also show that certain gene abnormalities are
associated with the fasting insulin levels, lipids and obesity of the metabolic syndrome.
Kushner and Bessesen (2007) indicate that physical inactivity contributes to the
risk of developing obesity related diseases, like metabolic syndrome. They give an
example of the Harvard alumni study which reports that individuals participating in
regular moderate intensity exercise activity have lower body weight in comparison to
those reporting less physical activity. They highlight the importance of establishing
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public health programs and interventions that address these issues and in turn help curb
the obesity epidemic. The role of lifestyle is emphasized in the current study.
Novak and Levine (2007) show that sedentary behaviors increase as physical
activity decreases which leads to increased obesity and decreased health at the population
level. They report that weight gain comes as a result of lower energy expenditure when
compared to caloric intake. "Indeed increasing physical activity levels may be the
missing link needed to reverse the current obesity trends" (p. 923).
In most studies, physical activity is associated with a decreased risk of metabolic
syndrome. Structured physical activity may help prevent metabolic syndrome (Ford et al.,
2005). Laaksonen et al. (2002) conducted a study on 612 individuals without metabolic
syndrome to assess the role of physical activity in predicting metabolic syndrome
development. Their results show that individuals practicing 3 or more hours of structured
physical activity per week have decreased risk of developing metabolic syndrome by
50%. Their results also showed that among high risk individuals, moderate to vigorous
exercise was effective in reducing their risk of developing metabolic syndrome.
In another study by Ford et al. (2005), individuals not participating in any
moderate or vigorous exercise during their leisure time showed twice the risk of
developing metabolic syndrome, outlining the fact that "excess weight and lack of
physical activity are two important determinants of the metabolic syndrome" p. 608).
"Increasing physical activity at the population level not only has potential to help
tackle the obesity problem, but would also address many of the other key health
problems" (Fox & Hillsdon, 2007, p. 116). The authors recommend that promoting
physical activity is needed now more than ever before. For example, fewer current jobs

require physical activity; labor saving equipment is being used in the home, work and
even in retail establishments, changes in shopping patterns with the emergence of the
internet, and increased self sufficiency in the home. Collectively these reasons have led to
a reduction in energy expenditure, which in turn played a role in increasing related health
problems. In regard to sedentariness, authors indicate that sitting and obesity are related
in a dose response manner, as obesity risk increases with the increase in time spent sitting
during leisure time. Additionally, this risk increases with the increase in time spent in the
car while travelling. They conclude by recommending that reduction in this sedentary
time should be a target for interventions and health policy (Fox & Hillsdon, 2007).
One way to increase physical activity both on an individual and population level
is through increasing non-exercise activity thermogenesis (NEAT), which is the energy
used when conducting different life activities. James Levine (2007) describes it as
"NEAT includes all those activities that render us vibrant, unique, and independent
beings such as dancing, going to work or school, shoveling snow, playing the guitar,
swimming, or walking in the modern mall" (p. 275). This includes movement of muscle
groups that is not performed for the purpose of exercise, but for the purpose of fulfilling
the requirements of daily life.
Levine and Miller (2007) indicate that during the last 20 years the work
environment shifted mainly to be a computer based one which contributed to a major
reduction in energy expenditure and physical activity levels, whether at the individual or
population level. They conducted a study assessing the effectiveness of NEAT in
increasing energy expenditure during work time. They recruited 15 individuals and asked
them to work on a vertical station composed of a treadmill with a computer on top of it,

instead of the typical work station or desk. Their results showed a significant increase in
energy expenditure during walking. Additionally, it showed a linear relationship between
walking speed and energy expenditure in these individuals. Lanningham, Nysse, and
Levine (2003) studied the difference in energy expenditure between using the elevator,
dishwasher, and driving in compare to walking, taking the stairs, and washing dishes
manually. The results showed that using the former three options increases ones energy
expenditure by 120 calories per day. They conclude that this adds up to 12 pounds of fat
per year.
Levine and Kotz (2005) indicate that obesity is associated with a predisposition to
be seated for a longer period of time in comparison to more lean individuals. The authors
conclude that if obese individuals used this time to stand or ambulate they would enhance
their energy expenditure by 350 kcal/day. Novak and Levine (2007) report that NEAT
has an important influence on energy expenditure, that even small changes in NEAT
overtime may have an influence on body weight. Wilson indicates that "NEAT may
explain the majority of the difference between individuals in terms of their energy
expended in a given day. In fact, it ranges from 15-50% of total calories expended in a
given day depending on whether an individual is sedentary or active" (Wilson, 2004,
p.2).
According to Kate Trainor (2009) "the beauty of NEAT is that you can start
anytime, anywhere. No need to wait for a gym membership to kick in or a new year to
turn over, it's easy to incorporate" (p. 2). For an ideal NEAT office environment, Trainor
recommends several NEAT enhancing activities such as replacing the chair with a
treadmill or an exercise ball, or standing when on the phone while using a mini-sized
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stepper. Also, Wilson suggests several items on how to enhance ones daily NEAT at
work, for an example, to ignore the elevator and use the stairs, or to ambulate when
reading instead of sitting (Wilson, 2004).
Levine (2007) recommends two approaches to make people more active during
their day. The first is an 'individualized approach' where NEAT enhancing activities are
personalized according to ones daily life activities. The second is 'environmental reengineering' and involves changing the surrounding environment, whether at the house or
at work. While other factors play a role in overall energy expenditure balance, the current
study will be an attempt to increase NEAT specifically through certain lifestyle
modifications associated with an individual's environment, or daily habits, by using
NEAT enhancing activities.
Novak and Levine (2007) suggest that NEAT may have an important contribution
to overall energy expenditure, as small changes in physical activity overtime may have
influence on body weight. For many, maintaining a healthy diet and regular exercise may
be difficult goals to achieve which is why the authors recommend NEAT as an easy and
accessible way to increase energy expenditure.
B. Purpose of the Study
The goal of this study was to determine whether NEAT can be used to reduce the
burden associated with metabolic syndrome in Qatari patients. This was planned to be
achieved by increasing the amount of energy used or calories burned throughout the day
utilizing NEAT. The specific objectives of this study were: (a) to examine the effect of
NEAT on the number of components of metabolic syndrome, and (b) to examine the
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effect of NEAT on the number of subjects meeting the IDF definition of metabolic
syndrome.
C. Research Questions
•

Among men and women with metabolic syndrome, does advice to increase NEAT
reduce the number of components of metabolic syndrome after I year?
o

Among men and women with metabolic syndrome, does advice to
increase NEAT improve their waist circumference after 1 year?

o

Among men and women with metabolic syndrome, does advice to
increase NEAT improve their glucose level after 1 year?

o

Among men and women with metabolic syndrome, does advice to
increase NEAT improve their HDL levels after 1 year?

o

Among men and women with metabolic syndrome, does advice to
increase NEAT improve their triglycerides levels after I year?

o

Among men and women with metabolic syndrome, does advice to
increase NEAT improve their blood pressure after I year?

o

Among men and women with metabolic syndrome, does advice to
increase NEAT improve their weight after I year?

•

Among men and women with metabolic syndrome, does advice to increase NEAT
reduce the proportion of subjects meeting the IDF definition of metabolic
syndrome?
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D. Theoretical Justification
1. Components of Human Energy Balance
Human energy expenditure is divided into three major components: first,
resting metabolic rate (RMR), which is the energy used at rest, and accounts for
approximately 60% of energy expenditure in humans (Wilson, 2004). This is the energy
needed for body functions like respiration, ion transport, blood flow, and maintaining
cellular integrity. For men, the RMR is approximately equivalent to 1800 kcal, for a
70 kg adult. For women, the associated RMR for a 50 kg adult is 1300 kcal. For
sedentary individuals RMR may account for 50-70% of daily energy expenditure (Harvey
& Ferrier, 2008). A study by Huang et al. (2004) showed higher RMR among severely
obese individuals with type 2 diabetes in comparison to those without diabetes. Another
study compared the RMR in obese, moderately obese and control individuals, and found
that obese individuals have significantly higher RMR in comparison to those with normal
weight (Ravussin et al., 1982). Thus, RMR is not a factor that is amenable to intervention
in people with metabolic syndrome.
The second component is the thermic effect of food. This is energy used during
eating, digesting, and processing food (Wilson, 2004). During these processes heat
production by the body increases as much as 30% above the normal resting level (Harvey
& Ferrier, 2008). This accounts for approximately 10-15% of overall energy expenditure
(Wilson, 2004).
The third component is activity thermogenesis which may be divided into
exercise and NEAT. This accounts for the remaining human energy expenditure (Wilson,
2004). This component of human energy expenditure usually accounts for the majority of
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variation in overall energy expenditure between different individuals and is most
amenable to intervention of the components of energy expenditure. For an example, a
sedentary individual may require 30-50% above resting caloric need, while a highly
active individual may need up to 100% or more calories above resting caloric need
(Harvey & Ferrier, 2008). While studies generally focus on increasing exercise,
increasing NEAT may be an effective way of increasing energy expenditure.
2. Non-exercise Activity Thermogenesis
NEAT is the energy expended while people conduct life activities other
than exercise, such as fidgeting and maintaining posture (NICHD, 2008). Levine defines
NEAT "as those activities that render us vibrant, unique and independent beings, such as
dancing, going to work or school, shoveling snow, playing the guitar, swimming, or
walking in the modern mall" (Levine, 2007, p. 275). Levine et al. identify four
environmental factors that have an influence on NEAT. First, the concrete urban
environment and mechanization, as comparing the energy cost of mechanization to
manual work shows that approximately 111 kcal per day is lost to mechanization.
Second, gender, as women may have more duties than men in some societies. Third,
education, as reports show that educated individuals report more leisure time in
comparison to those with less education. Fourth, seasonal variations in physical activity
(Levine et al., 2006) as reports from agricultural societies show that NEAT doubles in the
summer as compared to the winter time (Wilson, 2004).
Levine et al. (2006) show that NEAT plays an important role in overall energy
balance because it may vary as much as 2000 kcal/day between individuals. Moreover,
they indicate that highly active people may expend as much as three times more than
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inactive people. In 2006, a study conducted at the Mayo Clinic, one of the prominent
research institutes on the topic, found that the mean energy expenditure while seated was
approximately 70 kcal/h, in contrast to walking and working which was about 190 kcal/h,
with the mean increase of energy expenditure at approximately 120 kcal/h. The study
concluded that replacing time sitting at the desk by time walking and working,
individuals would lose 20-30 kg per year, if other components of energy expenditure
remained the same (Levine & Miller, 2007).
In another study by Levine, the author indicates that when a person walks at
1 mile per hour, instead of sitting, the energy expenditure of a 70 kg person is
approximately 100 kcal/h (Levine, 2007). Levine and Kotz (2005),in a third study,
indicate that obesity is associated with a predisposition to be seated for a longer period of
time in comparison to more lean individuals (about 160 min/day), and if these individuals
used this time to stand or ambulate they would spend up to 350 kcal/day (Levine & Kotz,
2005).
3. Non-exercise Activity Thermogenesis Mechanisms in Reducing
Components of Metabolic Syndrome
As identified by the harmonized definition of metabolic syndrome, the
main components are elevated waist circumference, elevated triglycerides or drug
treatment for elevated triglycerides, reduced HDL cholesterol or drug treatment for
reduced HDL cholesterol, elevated blood pressure or drug treatment for hypertension,
and elevated fasting glucose or drug treatment for elevated glucose.
a. Elevated Waist Circumference. Fan (2007) indicates that adipose tissue
is a metabolic and endocrine organ that is highly active, as it is responsible for releasing
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fatty acids, cytokines, and inflammatory mediators. This may contribute to the
cardiovascular and metabolic risk associated with metabolic syndrome. Ford et al. (2005)
indicate that physical activity and metabolic syndrome are inversely associated, as
sedentary behaviors contribute to different components of the syndrome. In the
previously mentioned study by Levine and Miller who compared the energy expenditure
of persons sitting in front of a computer screen to those using a 'walk and work' desk
station, the results show that there was a mean increase in energy expenditure for using
the station over sitting of 119 kcal/h. The authors conclude that if obese individuals
replace their sitting time with walking, an annual weight loss of 20-30 kg may occur
(Levine & Miller, 2007).
In a study by Levine et al. (1999), NEAT was found to be a significant predictor
of resistance to fat gain with overfeeding (r = 0.77, p < 0.001), as participants with higher
levels of NEAT had lower fat available for storage, in compare to those with lower levels
of NEAT and higher predisposition for obesity. The authors conclude that enhancing
NEAT through behavior modification may be useful in preventing obesity.
Levine and Yeager (2009) show that choosing a more active option during daily
activities increases energy expenditure. For an example a person would spend
approximately 15 calories when parking the car next to work and using the elevator,
while the amount of calories burnt increases to approximately 80-120 if parking was
further away and the stairs were used instead. The table below provides further examples
of more active options.
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Typical day at the

Calories burned

Picking up the pace

Calories burned

office
Park by building,

15

Park 5 blocks from

80-120

office, take stairs

take elevator
Make phone calls

15

100-130

up and pacing

for an hour at desk
Seated 45 minute

Take calls standing

25

Walk 30 minutes to

100-130

lunch, sit and eat 15

lunch

minutes
Seated 1 hour lunch

15

1 hour walking

150-200

meeting
Take elevator to

15

Take stairs out of

ground floor, walk

the building, walk

to car, drive home

back to car

Total

Total

85

80-100

510-680

b. Lipids. ManTugat et al. conducted a study on 537. individuals to assess
the role of physical activity in modifying the different components of their lipid profile.
Their results show that individuals participating in leisure physical activity greater than
7 kcal/minute had a significant increase in their HDL cholesterol and reduction in their
atherogenic index, independent from other confounding variables. Additionally, it
showed that participating in physical activity with intensity higher than 9 kcal/minute was
associated with decrease in total cholesterol and non HDL cholesterol (Marrugat et al.,
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1996). Gutierrez recommends physical activity and exercise as an adjunctive intervention
because of its positive impact on abnormal lipids. Exercise improves HDL cholesterol
levels through altering composition and maturation of the particles, as it increases the size
of HDL particles and the maturation of the nascent HDL particle. Additionally it
improves total cholesterol levels (Gutierrez, 2007). The improvement in HDL cholesterol
levels is due to increase in lipoprotein lipase activity which is responsible for breaking
down triglycerides (Kravitz & Hayward, 2011).
Kraus and Slentz (2009) indicate that moderate intensity exercise is significantly
more effective in improving triglyceride levels and insulin sensitivity than vigorous
intensity exercise. Additionally, it significantly improved a composite score for metabolic
syndrome. They suggest that regular walking is an effective method in reducing health
risk including the risk of developing cardiovascular disease, which comes through
favorable changes in fasting lipids and atherogenic dyslipidemia.
c. Glucose. Reaven (2002) indicates that resistance to insulin mediated
glucose disposal increases a person's risk of developing abnormalities associated with the
metabolic syndrome. He shows that physical activity enhances insulin sensitivity which
in turn reduces the risk of CVD. Grundy et al. (2005) indicates that insulin resistance is
an essential cause of metabolic syndrome, as it contributes to hyperglycemia of type 2
diabetes. Additionally, insulin resistant individuals usually have abnormal fat distribution
which is characterized by upper body fat. The authors show that the high release of fatty
acids contributes to the accumulation of lipids in other sites than adipose tissue such as
liver and muscles which contributes to worsening insulin resistance in the muscles for an
example. Furthermore, they show that in patients with metabolic syndrome, physical

16

activity may delay or prevent the development .of type 2 diabetes. They further conclude
by indicating that glycemic control reduces both associated microvascular and
macrovascular complications.
Healy etal.. (2007) showed a significant association between the effect of light
intensity physical activity and glucose levels among 173 participants. They concluded the
substitution of light intensity activity for other sedentary time may be a successful
prevention method that contributes to the reduction of both type 2 diabetes and CVD risk.
In another study, Gordon et al. (2008) looked into the effects of yoga and exercise
combined in comparison to a control group on lipids among 77 patients with type 2
diabetes. This 6-month study showed significant reductions in fasting blood glucose and
both total cholesterol and VLDL cholesterol levels. They concluded that yoga and
exercise can be used as a preventive therapeutic measure for type 2 diabetes patients.
Another study looked into the effect of aerobic exercise and impaired fasting
glucose and type 2 diabetes. This was a prospective study, with an average follow up of
6 years, which was conducted on 8633 individuals without diabetes. These were divided
into three groups with low, moderate, and high fitness. The results showed that those in
the low fitness level have a 3.7 fold greater risk of developing diabetes in comparison to
those in the high fitness group. Additionally it showed a dose response gradient between
the assigned fitness level and incidence of both impaired fasting glucose and diabetes.
They concluded that a sedentary lifestyle is a contributor to the progression from normal
fasting glucose to impaired fasting glucose and diabetes (Wei et al., 1999).
d. High Blood Pressure. Reaven (2002) indicates that patients with
hypertension are at higher risk of developing cardiovascular disease. Grundy et al. (2005)
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show that lifestyle changes are crucial in hypertensive individuals with metabolic
syndrome. They recommend physical activity as a tool to help control elevations in blood
pressure. The Mayo Clinic on their website indicates that not getting enough exercise and
having high blood pressure are closely related. For some, participating in regular physical
activity lowers the need for anti hypertensive medication. They show that physical
activity helps in strengthening the heart so that it requires less effort to pump blood
through the arteries which helps lower blood pressure (Mayo Clinic, 2011).
Arroll and Beaglehole (1992) show that physical activity reduces blood pressure
in both hypertensive and non hypertensive individuals, with an average reduction of 6-7
mmHg for both systolic and diastolic blood pressure, indicating that this is comparable to
drug treatment for hypertension, and concluding that this effect is independent from other
factors. The results of another study by Padilla et al. (2005) shows that physical activity
is effective in reducing systolic blood pressure in hypertensive and prehypertensive
individuals, suggesting that physical activity may be used to treat both hypertension and
prehypertension. Another study by Kerrie et al. (2001) showed that walking for 30
minutes over a 24 week period reduced systolic blood pressure in women with borderline
to stage 1 hypertension.
In this study, NEAT is used to increase the energy expenditure among participants
in the intervention group, which reflects positively on the waist circumference, glucose
level, blood pressure, and lipid profile, which in turn reflects on the number of metabolic
syndrome components along with the number of patients. The theoretical framework of
this study is outlined in Figure 1.1.
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HUMAN ENERGY
Activity
thermogenesis

EXPENDITURE

Basal metabolic
rate

Food thermic
effect

Improve health and decrease
risk of developing disease

Figure 1.1 NEAT contributes to energy expenditure by causing more calories to be
burned, which may reduce the number of metabolic syndrome components and the
number of subjects with metabolic syndrome.
E. Significance to Preventive Care
The results of this study may provide preventive care specialists with another tool
that may aid in improving the health of subjects with metabolic syndrome, through
reduction in the number of metabolic syndrome components. A tool that may be used as
part of overall lifestyle recommendations given by preventive care specialists to improve
the life quality of subjects with metabolic syndrome. It may also have an impact for
recommendations given to individuals who feel they cannot exercise or are not motivated
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to do so. In the long run, increasing the amount of energy used throughout the day
utilizing NEAT, may be further reflected in a lowering of certain metabolic syndrome
markers, and or decreasing risk of developing metabolic syndrome, and decreased risk for
developing cardiovascular disease and or type 2 diabetes.
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CHAPTER 2
LITERATURE REVIEW

A. Overview
The increasing prevalence of metabolic syndrome in Qatar is just one indication
among many that this population is suffering as a result of major lifestyle changes that
have occurred in the past four decades. This literature review should serve to (a) identify
factors behind the rise of metabolic syndrome prevalence, (b) evaluate current efforts to
curb the prevalence, and (c) explore possibilities of improving the overall quality of life
among metabolic syndrome patients.
This literature review is divided into two main sections. The first covers an
overview of metabolic syndrome along with its different definitions, the prevalence
globally and in Qatar, risk factors, and implications. The second part discusses NEAT;
how it has been used previously, how it has been used in the current study, how it
influences energy expenditure, and recent studies on the topic.
After conducting my research over the past few months, it was found that Dr.
James Levine at The Mayo Clinic has provided the foundation of work done on NEAT.
Several of his studies on the topic will be covered here.
B. Metabolic Syndrome Overview
Metabolic syndrome is a health condition which involves a combination of
abnormalities in one person, this may include but not limited to the following items; high
blood pressure (hypertension), elevated levels of fasting, glucose, insulin resistance
(Bener et al., 2009), obesity especially central obesity characterized by accumulation of
fat in the abdomen, dyslipedimia characterized by low levels of HDL cholesterol, also
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known as "good cholesterol", and high levels of triglycerides (Meigs, 2003). The
constellation of the above items increases the risk of developing diabetes, or
cardiovascular disease (CVD) (Bener et al., 2009) and ultimately increasing the risk of
mortality (International Diabetes Federation (IDF), 2006). For an example, Grundy et al.
(2005) showed that adipose tissue among obese individuals is usually insulin resistant
which increases fatty acid levels, thus increasing insulin resistance in muscle tissue.
Furthermore, this adipose tissue produces abnormal adipokines which also alters insulin
resistance and increases risk for CVD. The health risk associated with metabolic
syndrome is discussed in more detail under the clinical implications section.
Factors that play an important role in the development of this disease include
genetics, sedentary lifestyle, cigarette smoking, progressive weight gain, and a Western
diet (Pitsavos et al., 2007; Schiltz et al., 2009). Lifestyle plays a major role in the etiology
of metabolic syndrome either through low physical activity or excess caloric intake or
both. The most common risk factor seems to be abdominal obesity which majorly
justifies lifestyle modification. The American Heart Association states that "in the long
run, the greatest benefit for those with metabolic syndrome will be derived from effective
lifestyle intervention" (Minich & Bland, 2008).
C. Different Criteria for Metabolic Syndrome
Several criteria establish the diagnosis of metabolic syndrome, these vary by
geographical region or by the organization that issues the definition. Currently, five
definitions of metabolic syndrome exist, these were established by the World Health
Organization (WHO) in 1999. the American Association of Clinical Endocrinologists
(AACE) in 2003, the European Group for the Study of Insulin Resistance (EGIR) in
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1999, the International Diabetes Federation (IDF) in 2004, and the National Cholesterol
Education Program/Adult Treatment Panel III (NCEP/ ATP III) in 2001 (Meigs, 2004).
The most popular and widely used are the definitions by the National Cholesterol
Education Program and the International Diabetes Federation and more recently the
harmonized definition; these are discussed in detail below.
1. Harmonized Definition of Metabolic Syndrome
The patient must have three or more of the following five abnormalities;
(a) Elevated waist circumference which is population and country specific; (b) Elevated
triglycerides over or equal to 150 mg/dL (1.7 mmol/L), or drug treatment for elevated
triglycerides; (c) Reduced HDL cholesterol less than 40 mg/dL for males and less than
50 mg/dL for females, or drug treatment for reduced HDL cholesterol; (d) Elevated blood
pressure over or equal to 130 mm Hg for systolic and/or over or equal to 85 mm Hg for
diastolic, or drug treatment for hypertension; (e) Elevated fasting glucose above or equal
to 100 mg/dL, or drug treatment for elevated glucose (Alberti et al., 2009).
2. International Diabetes Federation
Central obesity is the primary criteria with different cutoff scores for
different ethnicities, with elevated waist circumference of over or equal to 94 cm for men,
and 80 cm for women. Additionally, the patient must have two or more abnormalities out
of four of the following,: (a) Triglycerides over or equal to150 mg/dL (1.7 mmol/L), or
treatment for elevated triglycerides; (b) HDL cholesterol less than 40 mg/dL
(1.0 mmol/L) for men, and 50 mg/dL (1.3 mmol/L) for women, or treatment for low HDL
cholesterol; (c) High blood pressure over or equal to 130/85 mmHg, or treatment for
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hypertension; (d) Fasting plasma glucose over or equal to 100 mg/dL (5.6 mmol/L), or
diagnosed type 2 diabetes (IDF, 2006).
3. National Cholesterol Education Program/Adult Treatment Panel III
The patient must have three or more of the following five abnormalities;
(a) Obesity characterized by waist circumference over or equal to 102 cm (40.15 inch) for
men, and over or equal to 88 cm (34.64 inch) for women; (b) Triglycerides over or equal
to150 mg/dL (1.7 mmol/L), or treatment for elevated triglycerides; (c) HDL cholesterol
less than 40 mg/dL (1,0 mmol/L) for men, and 50 mg/dL(1.3 mmol/L) for women, or
treatment for low HDL; (d) High blood pressure over or equal to 130/85 mmHg, or
treatment for hypertension; (e) Fasting plasma glucose over or equal to 100 mg/dL (5.6
mmol/L), or drug treatment for elevated blood glucose (Meigs, 2004).
D. Metabolic Syndrome Prevalence Worldwide
"The metabolic syndrome is very common and will become even more common
as populations age and become more obese" states Meigs in a report in 2002 (p. 283).
Estimates by the International Diabetes Federation in 2005 in regard to the worldwide
prevalence of metabolic syndrome indicate that approximately 25% of the population
suffers the burden of symptoms related to metabolic syndrome (IDF, 2006). Other studies
show that up to 30% of middle aged individuals in developed nations have several
features of this disease, with prevalence increasing up to 60 % of individuals in their
70's, with a minimal 30% of all adults living without any features (Haslam, 2005).
In the United States, according to the National Center for Health Statistics in a
report published in 2009, approximately 34% of adults meet the criteria set by the
National Cholesterol Education Program/Adult Treatment Panel III (Ervin, 2009). For the
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age category under 40 years, 20% of males and 16% of females meet the criteria. For the
age category 40-59 years, 41% of males and 37% of females meet the criteria. And
finally, for the age category 60 years and over, 52% of males and 54% of females meet
the criteria. Ethnicity wise, 25% of non Hispanic Black males meet the criteria in
comparison to 37% of non Hispanic White males (Ervin, 2009). In a different study,
Meigs indicates that about 24% of the US population between ages 20-70 have the
syndrome, which is more common in older and Mexican American individuals (Meigs,
2002). A third study estimates that 69 million American meet the criteria set by the
International Diabetes Federation (Schiltz et al., 2009).
E. Metabolic Syndrome Prevalence in Qatar
In a recent study by Musalam et al., the Qatari population was found to have high
prevalence rates of obesity, diabetes, and further with metabolic syndrome prevalence
rates of 27.6% (ATP III criteria) and 35.4% (IDF criteria) (Musalam et al., 2008). Bener
et al. (2009) attribute this to the general economic growth witnessed in that geographic
area. Bener, Zirie, and Al-Rikabi, (2005) find that this influences levels of urbanizations
and lifestyle leading to increases in diabetes mellitus to the point where many consider it
a main public health concern in the country. Additionally, the hot weather environment
seems to be a factor that limits or restricts physical activity opportunities (Musalam et al.,
2008). Al-Sarraj reports similar results from the neighboring United Arab Emirates
(UAE), where prevalence rates indicate that 39% and 40% of the population has
metabolic syndrome, according to ATP and IDF respectively (Al-Sarraj 2010).
The socio-demographic characteristics breakdown of metabolic syndrome patients
in Qatar, show age and body mass index (BMI) as significant contributors to the
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prevalence of the disease in Qatar. It also shows a significant relationship with gender,
and educational status. In regard to gender, females had higher prevalence rates.
According to the IDF criteria, 61% of females have metabolic syndrome in comparison to
38.6% of men, the ATP criteria showed lower rates with 56.3% for females, and 43.3%
for males (Bener et al., 2009). These results are similar to prevalence studies conducted
in different geographic regions of the world, like the United Kingdom where females had
a higher prevalence rate of metabolic syndrome 24.9%, in comparison to 17.4% for men
(Santos et al., 2008). Or like Slovakia, where females report 23.9% in comparison to
15.9% males (Mokan et al., 2008).
F. _Metabolic Syndrome Risk Factors
The Mayo clinic on their website lists the following items as risk factors for
metabolic syndrome. The first factor is age, as the risk of developing metabolic syndrome
increases with age. Reports show that metabolic syndrome affects about 10% of those in
their twenties in comparison to 40% of those that are in their sixties. The second factor is
diabetes, as the risk of developing metabolic syndrome increases with family history of
type 2 diabetes, or gestational diabetes. The third factor is race, as some ethnicities seem
to have higher risk of developing this syndrome, such as Hispanics or Asians. The fourth
factor is obesity, as a body mass index (BMI) above 25 increases the risk of developing
the metabolic syndrome. The fifth factor is other diseases, such as high blood pressure,
cardiovascular disease, or polycystic ovary syndrome may increase risk of developing
metabolic syndrome (Mayo Clinic, 2009). Meigs indicates that age, weight, and race are
common risk factors for metabolic syndrome. Additionally, postmenopausal status,
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smoking, low household income, high carbohydrate diet, and physical inactivity may also
increase the risk of developing metabolic syndrome (Meigs, 2004).
Two researchers have studied these risk factors in metabolic syndrome patients in
Qatar. Mussalam et al. (2008) found abdominal obesity to be the most common factor
among Qatari patients, which also seems to be more prevalent among females, as
abdominal obesity prevalence for Qatari females was estimated at 74% in comparison to
56% for males. Other contributing risk factors reported in the study were genetics,
environmental factors leading to physical inactivity, and high illiteracy rate (11.8%). In a
different study, Bener et al. (2009) found that gender, age, and educational status, are
significant contributors to metabolic syndrome in this population. This study also showed
a nine fold increase in age specific prevalence, when comparing the age group 20-30
(7.9%) with the age group 60 and above (70.3%).
G. Metabolic Syndrome Clinical Implications
Metabolic syndrome is a medical condition associated with modern western
civilizations, with many risk factors that come with the name; along comes higher
susceptibility to a long list of crucial and serious illnesses. Many sources consider this
disease a major global public health issue that requires a multi factorial effort to curb the
increasing prevalence. For example, Meigs indicates that patients with metabolic
syndrome have double the risk of developing CVD, and have four times the risk of
developing type 2 diabetes in comparison to individuals not classified under metabolic
syndrome (Meigs, 2002).
The Metabolic Syndrome Institute associates metabolic syndrome with an
increased risk of coronary heart disease, myocardial infarction, and stroke in both
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genders. Furthermore, the institute indicates that metabolic syndrome patients are three
times more likely to suffer a cardiovascular event as compared to non-metabolic
syndrome individuals (Metabolic Syndrome Institute, 2010). These associations are
similar to ones reported in a study conducted by Isomaa et al. (2001), where 3606
metabolic syndrome patients were followed for 6.9 years. Individuals with metabolic
syndrome were found to have three times the risk of coronary heart disease, myocardial
infarction, and stroke in comparison to those without it. Metabolic syndrome patients also
had a 1.8 times the risk of cardiovascular morbidity.
H. Components of Human Energy Balance
Total human energy expenditure is divided into three major components; these are
basal metabolic rate, thermic effect of food, and activity thermogenesis (Levine, 2007).
Basal metabolic rate (BMR), or resting metabolic rate (RMR), is the energy used for core
body functions and is measured during rest while fasting. This contributes to 60-70% of
all energy utilized, and usually varies by size, the bigger the person the higher the basal
metabolic rate. Thermic effect of food accounts for about 10-15% of all energy utilized
and represents the energy needed for digestion, absorption, and storage. For example,
proteins have the highest thermic effect of all macronutrients, which is followed by
carbohydrates and then fats (Wilson, 2004).
Activity thermogenesis accounts for the rest of the energy utilized throughout the
day, and divides into two components, exercise activity and non-exercise activity
thermogenesis (NEAT). The former is the energy used when exercising, and the latter is
the energy used throughout the day for all non-exercise activities, such as shopping,
mowing the lawn, or fidgeting. This part plays an important role in overall energy
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balance, and may vary as much as 2000 kcal/day between individuals, which makes it an
important tool in weight loss or in preventing weight gain (Levine, 2007).
I. Non-exercise Activity Thermogenesis (NEAT)
James Levine (2007) describes it as "NEAT includes all those activities that
render us vibrant, unique, and independent beings such as dancing, going to work or
school, shoveling snow, playing the guitar, swimming, or walking in the modern mall"
(p. 275). Some of the activities that classify under NEAT—listed in ascending order of
energy expenditure- include standing, gum chewing, fidgeting, stair climbing, and
walking.
J. Non-exercise Activity Thermogenesis and Obesity
It is estimated that 1 billion individuals across the globe are overweight or obese;
this comes as a result of the increased sedentary lifestyle behaviors (Novak & Levine,
2007). A study conducted at Mayo clinic in 2006, one of the prominent research institutes
on the topic, found that the mean energy expenditure while seated was approximately
70 kcal/h, in comparison to walking and working which was about 190 kcal/h, with the
mean increase of energy expenditure at approximately 120 kcal/h. The study concluded
that replacing time sitting at the desk by time walking and working, individuals would
lose 20-30 kg annually if remaining energy components remained the same (Levine &
Miller, 2007).
In another study by Levine, the author indicates that when a person walks at
1 mile per hour, instead of sitting, the energy expenditure of a 70 kg person is
approximately 100 kcal/h (Levine, 2007). Levine and Kotz (2005) in a third study
indicate that obesity is associated with a predisposition to be seated for a longer period of
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time in compare to more lean individuals (about 160 min/day), and if these individuals
used this time to stand or ambulate they would spend up to 350 kcal/day.
K. Non-exercise Activity Thermogenesis Strategies
Examples of activities classified under NEAT—listed in ascending order of
energy expenditure- include; standing, gum chewing, and fidgeting (Levine, 2007). A
comparison of the energy expenditure associated with each item is shown in Figure 2.1.
For example, when a person stands instead of sitting, energy expenditure is increased by
10% above rest. When a person chews gum, energy expenditure is increased by 20%
above rest. When fidgeting, energy expenditure is increased by 50%, and when a person
walks at one mile per hour energy expenditure is doubled (Increasing the rate to three
miles per hour increases expenditure by 250%) (Wilson, 2004).
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Figure 2.1 Energy expenditure during different activities in comparison to rest (Levine,
2007).
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NEAT can be divided into NEAT associated with leisure activities, and NEAT
associated with occupation or work (Levine, 2007). To promote individual NEAT
strategies, Levine recommends the following steps: (a) self monitoring and feedback,
(b) modify specific seated behaviors so that they can be performed while standing, (c) use
sedentary behaviors to reinforce physically active choices, (d) identify substitutes of
sedentary behaviors, (e) stimulus control, both at work and home, and (0 presence of a
motivated team (Levine et al., 2006).
Kate Trainor states "the beauty of NEAT is that you can start anytime,
anywhere." Simple items like using the stairs instead if the elevator may burn 12 calories.
Or like walking the dog which burns 200 calories per hour or up to the 300 calories if it
was a one hour jog, may increase ones daily NEAT (Trainor, 2009). Strategies that
increase NEAT at the office or work environment include (a) replacing the chair with a
treadmill or exercise ball; (b) keeping exercise equipment handy, like mini sized steppers;
(c) using a pedometer to measure the amount of steps per day with a goal of 10,000 steps;
(d) keeping walking or running shoes accessible, near the desk; (e) walking while using
the phone (Trainor, 2009).
To help ease NEAT into individuals life, Levine recommends the following steps,
represented by the acronym STRIPE: (a) Select a NEAT activity that is enjoyable to start
with, (b) Targeted, goals must be well defined, (c) Reward must be per goal, (d) Identify
barriers and work on overcoming them, (e) Plan NEAT activity sessions, (0 Evaluate
adherence (Levine, 2007).
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L. Non-exercise Activity Thermogenesis Measurement
Several methods that measure NEAT are currently available. For example, Levine
and Miller used a vertical work station—instead of the typical horizontal one—to assess
energy expenditure in one of his many studies on the topic. The new work station, which
he called "walk and work desk" was designed so that participants can walk on a treadmill
while conducting normal office work on their personal computer which was placed on
top of the treadmill. The study reports a mean increase in energy expenditure of 119
kcal/h when using the walk and work desk compared to sitting (Levine & Miller, 2007).
In a clinical trial conducted by the United States government in 2006, which was
sponsored by the Eunice Kennedy Shriver National Institute of Child Health and Human
Development (NICHD), participants wore a timed device that vibrates at pre-set intervals
and measures the amount of NEAT, the results have not been published yet (Nonexercise Activity Thennogenesis, 2008). Other options that measure energy expenditure
include pedometers and accelerometers. Some high tech accelerometers can save data for
days and allows easy transfer to a computer data base for analysis (Kushner & Bessesen,
2007).
M. Conclusions
The Metabolic Syndrome Institute associates metabolic syndrome with an
increased risk of coronary heart disease, myocardial infarction, and stroke in both
genders. Furthermore, the institute indicates that metabolic syndrome patients are three
times more likely to suffer a cardiovascular event in compare to non metabolic syndrome
individuals (Metabolic Syndrome Institute, 2010). Many studies cover the morbidity and
mortality of the metabolic syndrome; a lesser number covers it in relation to the Qatari
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population. From the little research done, it appears necessary to conduct more
experimental studies on this topic in this population, as the majority of information comes
from observational studies and personal reviews. In regard to NEAT, the unknown seems
to outweigh the known. Much more experimental research needs to be conducted in
relation to the mechanisms of how NEAT works, how it influences obesity, and how to
convince people to incorporate NEAT into their lives. The results of this study may be of
use for future preventive care specialists when counseling patients with metabolic
syndrome, as it adds another method that may be utilized for calorie burning on daily
basis.
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CHAPTER 3
METHODS

A. Design
The study is a randomized experiment, with a pretest and posttest control group.
There are 200 metabolic syndrome patients, ages 18 and above from Qatar. NEAT
enhancing activities were used as a lifestyle intervention over a one year period.
Following the outline shown in Table 1, subjects were followed up twice after baseline
measurements were taken. Figure 3.1 shows the overall design of the study according to
Shadish, Cook, and Campbell (2002) notation.

Baseline

0
R

0

6 months

x

1 year

x

0
0

0
0

Experimental group
Control group

Figure 3.1 The design using Shadish, Cook, & Campbell notation, where X = treatment,
0 = observation, R = randomized.
B. Participants
A total of 200 subjects with metabolic syndrome were recruited from the
endocrinology and diabetes department clinics at Hamad Medical Corporation in Doha,
Qatar. The endocrinologist introduced the study to his patients; the ones who decided to
participate later met with the nurse for a health assessment, and to sign the consent form.
Finally, subjects met with the research assistant for educational material and further

34

details. Participants were asked to provide demographic data during the initial health
assessment visit. A designed questionnaire was used to collect patient information such
as age, gender, and marital status. Additional information collected includes the reason
for referral, other co morbidities and medications at the start and end of study, along with
changes.
The IDF definition for metabolic syndrome was used to establish diagnosis (IDF,
2006). The inclusion criteria is: patients over the age of 18, who have elevated waist
circumference (over or equal to 94 cm for men, over or equal to 80 cm for women), and
two or more abnormalities out of four, of the following: (a) glucose levels over or equal
to 5.6 mmol/L, or diagnosed diabetes (b) blood pressure over or equal to 130/85 mmHg,
or drug treatment for hypertension (c) triglycerides levels over or equal to1.7 mmol/L, or
drug treatment for high triglycerides) (d) HDL levels less than 1,0 mmol/L for men and
less than 1.3 mmol/L for women, or drug treatment for low HDL.
The exclusion criteria excluded subjects (a) diagnosed with major illnesses,
(b) taking any type of medication that may affect weight, and (c) cannot tolerate study
procedures (NICHD, 2008).
C. Procedures
The research assistant randomized subjects to an intervention (n = 100) and a
control group (n = 100). The randomization list was produced using random allocation
software. The control group received general dietary and physical activity guidelines. The
intervention group additionally received information on how to increase their daily
NEAT. Subjects were followed for one year, during which the waist circumference and
lipid profile were assessed at baseline, 6, and 12 months. During each of these visits
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subjects met with the nurse for a weight assessment and to draw blood samples. Subjects
then met with the research assistant to report their NEAT activity and get educational
material.
A contracted marketing company sent a reminder of participation to subjects in
the intervention group via text messages at 2, 4, 8, and 10 months. The reminder included
the title of the study, along with instructions on NEAT enhancing activities. For follow
up visits at 6 and 12 months, participants received a reminder call of their appointment
date, one week and one day before their arranged appointments. These calls were carried
out by the nurse or the research assistant according to availability. The above procedures
were mentioned in detail in the informed consent and were described to subjects before
they decided whether or not to join.
D. Measurements
A Seca digital medical weighing scale was used to obtain weight information,
which was measured in kilograms. Waist circumference was assessed using a measure
tape at the level of the superior iliac crest with the person lightly clothed. The fasting
glucose and lipid profile were assessed by drawing blood samples, and submitting them
to the facility lab for a report. This includes information on the blood levels of (a) LDL
cholesterol, (b) HDL cholesterol, (c) total cholesterol, and (d) triglycerides. These were
measured in millimole per liter. The blood pressure was measured using an electronic
sphygmomanometer after the patient was seated for 10 minutes.
E. Intervention
Subjects were asked to practice the following, NEAT enhancing activities
recommended by Levine et al. (2006); standing instead of sitting, gum chewing,
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fidgeting, using the stairs instead of the elevator, walking instead of using the car. This
information along with the frequency was reported by the subjects on weekly report
sheets. These were turned in to the research assistant at the 6 and 12 month visit. A copy
of the report sheet is shown in Table 3.
F. Data Analysis
The analysis was based on the results of a repeated measure ANOVA test with
two groups, with data collected at baseline, 6 months, and 1 year. Results of both groups
were compared, then, results of the amount of NEAT were compared among the
intervention group. The independent variable was being in the intervention or the control
group. The dependent variables were (a) the change in the number of metabolic syndrome
components at baseline, 6 months, and 1 year; and (b) the change in the number of
subjects meeting criteria for metabolic syndrome, and were measured on a continuous
scale.
G. Power Analysis
Based on Cohen's (1992) estimation of a medium effect size (f=25),
power = 80%, and a = 0.05, 64 subjects were needed in each group for a total of 128. To
allow for any dropouts, the goal was to recruit 200 subjects, 100 per group, which
allowed for a good dropout rate.
H. Limitations
Randomization controls for some threats to validity such as maturation, history,
regression, instrumentation and selection. However, the design fails to control for other
sources of threats to internal validity: (a) It is possible that subjects interacted with each
other at the hospital due to the small size of the waiting room, which may have lead some
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from the control group to try the intervention on their own. (b) Self-report was used
during follow up visits where subjects may tend to over report, or simply forget.
(c) Under attrition, a high dropout rate was experienced.
The study also fails to control for sources of threats to construct validity:
(a) Compensatory equalization, it is possible that subjects from the control group may
have gotten access to information related to the intervention from the hospital personal
and decided to try it on their own. (b) Compensatory rivalry, it is possible that subjects
from the control group tried to show that they can do as well as the other group.
(c) Resentful demoralization, it is possible that subjects from the control group may have
become resentful because they didn't receive the intervention, and decided to drop out of
the trial. Finally, under external validity, because the study was conducted in a certain
geographic area and the patients were of a certain disease, the results of the study cannot
be generalized to other geographical areas or patients with other types of diseases.
I. Research Ethics
Under autonomy, subjects had the right to decide whether to join the study or not.
Those with diminished autonomy had the right to be protected from harm. Furthermore,
subjects were asked to sign a consent form, which is a ten page document that covers the
following items: (a) A description of the study and its purpose. (b) The information the
participant was asked to give. (c) A description of what the participant was asked to do
and for how long. (d) A description of potential risks and benefits. (e) A statement
indicating that participation is voluntary. (f) Reassurance that all data will be confidential.
(g) The name and number of a person the participant may call to get further information.
(h) The name and number of a person the participant may call if he has a complaint.
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(i) Information regarding compensation provided. (j) A description of alternatives to the
research. (k) Explanation that a summary of the results will be available if wanted.
(1) Places for signatures (Cone & Foster, 2006). Subjects were asked to sign the consent
form during the recruitment visit and before receiving any instructions.
For the sake of protecting patient confidentiality, these documents were kept in a
designated folder, placed in a locked filing cabinet, located in the assigned research room,
where the principal investigator was the only person who had access. Additionally, each
subject was assigned a tracking number, where the list of names and tracking numbers
were kept separately from the data and the tracking number. Under justice, subjects had
equal opportunity in participating and benefiting from the research, this was carried out
by excluding only those that meet the exclusion criteria, and not for any irrelevant factor
like age or gender. Participants were recruited fairly using randomization which allowed
each participant a 50% chance of being in either group. Also, subjects were informed of
alternative treatments. Under beneficence, harm was minimized and benefits were
maximized, any risks or advantages were revealed to subjects during the initial visit with
the research assistant.
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Abstract
Qatar shares the burden of much of the rest of the world with high prevalence of
metabolic syndrome. In a recent study, gender, age, and educational status were
significant contributors to metabolic syndrome in this population. Other studies associate
metabolic syndrome with an increased risk of coronary heart disease, myocardial
infarction, and stroke in both genders.
Total human energy expenditure is divided into three major components; resting
metabolic rate, thermic effect of food, and activity therrnogenesis which is divided into
exercise and non exercise activity thermogenesis (NEAT). In this study NEAT was used
as a lifestyle intervention on subjects with metabolic syndrome. 200 eligible patients
from the Diabetes and Endocrinology Department at Hamad Medical Hospital in Doha,
Qatar were assigned to an intervention (n=100) or control (n=100) group and followed
for one year. The intervention group was advised to practice NEAT enhancing activities,
while the control group was not advised about NEAT. Measurements of waist
circumference, weight, BMI, blood pressure, glucose and lipid profile were assessed at
baseline, 6 months, and 1 year. After one year 52 intervention and 55 control subjects
completed the study. The results revealed no statistically significant differences in
metabolic syndrome components between the two randomized groups. The amount of
recommended NEAT activity appears to have been too small to influence study
outcomes. Future studies in similar populations may need to consider the high dropout
rate, and use of incentives or other interventions to increase compliance and retention.
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Introduction
Metabolic syndrome is a combination of several abnormalities that increase the
risk of cardiovascular disease (CVD) such as increased waist circumference, lipids, or
blood pressure. Each abnormality is associated with cardiovascular disease cases (1), such
as stroke, myocardial infarction, and heart failure (2) . Worldwide, approximately 20-25%
of the population suffers the burden of symptoms related to metabolic syndrome (3). The
burden is shared among the Qatari population, which suffers from high prevalence rates
of obesity and type 2 diabetes (I). A recent study indicates that the crude prevalence of
metabolic syndrome in Qatar is 34% according to the International Diabetes Federation
(IDF) criteria (2). Risk factors associated with metabolic syndrome in the Qatari
population include age, ethnicity, obesity, and family history of diabetes (2).
Total human energy expenditure divides into basal metabolic rate, thermic effect
of food, and activity therniogenesis. Activity thennogenesis is further divided into
exercise, and non exercise activity thermogenesis (NEAT); NEAT is defined as the
energy used throughout the day for all non exercise activities (4) . Novak and Levine (5)
show an inverse relationship between sedentary behaviors and physical activity; which
leads to increased obesity and decreased health at the population level. Structured
physical activity may help prevent metabolic syndrome (6). One way to increase physical
activity both on an individual and population level is through increasing NEAT, such as
walking instead of driving, or taking the stairs instead of using the elevator.
Gutierrez recommends physical activity as an adjunctive intervention because of
its positive impact on abnormal lipids. Exercise improves HDL cholesterol levels through
altering composition and maturation of the particles, as it increases the size of HDL
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particles and the maturation of the nascent HDL particle. Additionally it improves total
cholesterol levels (7). Grundy et al. show that lifestyle changes are crucial in hypertensive
individuals with metabolic syndrome. They recommend physical activity as a tool to help
control elevations in blood pressure. Additionally, insulin resistant individuals usually
have abnormal fat distribution which is characterized by upper body fat. The authors
show that the high release of fatty acids contributes to the accumulation of lipids in other
sites than adipose tissue such as liver and muscles which contributes to worsening insulin
resistance in the muscles. Furthermore, they show that patients with metabolic syndrome
who are physically active may delay or prevent the development of type 2 diabetes (8).
A lifestyle intervention study was conducted with 200 Qatari subjects identified
with metabolic syndrome. This proof of concept study aims to understand whether it is
feasible to attempt to reduce the burden of metabolic syndrome in Qatari outpatients by
promoting increased NEAT.
Methods
The study is a one year randomized experiment, with a pretest and posttest
intervention and control group. The study was conducted between March 2010 and
August 2011. NEAT enhancing activities were used as a lifestyle intervention. Subjects
were recruited from the endocrinology and diabetes department clinics at Hamad Medical
Corporation in Doha, Qatar. Subjects were asked to sign a written consent form before
enrollment. The study was approved by the research ethics committee at Hamad Medical
Hospital in Doha, Qatar (research protocol number 9181/09). Permission for use of the
data for the first author's dissertation was given by the Institutional Review Board at
Loma Linda University.
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The IDF definition for metabolic syndrome was used to establish diagnosis (9).
The inclusion criteria included subjects over the age of 18, who have elevated waist
circumference (over or equal to 94 cm for men, over or equal to 80 cm for women), and
two or more abnormalities out of four, of the following: (a) elevated triglycerides over or
equal to 150 mg/dL (1.7 mmol/L), or drug treatment for elevated triglycerides;
(b) reduced HDL cholesterol less than 40 mg/dL (1.0 mmol/L) for males and less than 50
mg/dL (1.3 mmol/L) for females, or drug treatment for reduced HDL cholesterol;
(c) elevated blood pressure over or equal to 130 mm Hg for systolic and/or over or equal
to 85 mm Hg for diastolic, or diagnosed hypertension; and (d) elevated fasting glucose
above or equal to 100 mg/dL (5.6 mmol/L), or diagnosed diabetes. The exclusion criteria
excluded subjects: (a) diagnosed with major illnesses; (b) taking any type of medication
that may affect weight; (c) cannot tolerate study procedures(10).
Subjects were divided to an intervention (n = 100) and a control group (n = 100).
The randomized list was produced using random allocation software. The control group
received general dietary and physical activity guidelines. The intervention group received
additional information on how to increase their daily NEAT. This information was given
by the nurse, on a one to one basis, over a 10 minute period of time. Participants also
received a one page handout explaining different NEAT options and how it works.
Subjects were asked to practice the following NEAT enhancing activities recommended
by Levine et al.(4) standing instead of sitting, gum chewing, fidgeting, using the stairs
instead of the elevator, walking instead of using the car. This information along with the
frequency was reported by subjects on weekly report sheets that were turned in at their 6and 12-month visit.
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Subjects were followed for 1 year, during which the waist circumference, blood
pressure, weight, glucose and lipid profile were assessed at baseline, 6, and 12 months.
Subjects in the intervention group received reminders, via text messages, to practice
NEAT at 2, 4, 8, and 10 months.
Measurements
A Seca digital medical weighing scale was used to obtain body weight. Waist
circumference was assessed using a measure tape at the level of the superior iliac crest
with the person lightly clothed. The fasting glucose and lipid profile were assessed by
drawing blood samples. This included information on the blood levels of total
cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, and glucose (Roche/Hitachi
modular p chemistry analyzer using enzymatic in vitro assay) at the facility laboratory.
LDL cholesterol was calculated unless triglycerides were > 4.5 mmol/L, when it was
measured directly. The blood pressure was measured using an electronic
sphygmomanometer after the patient was seated for 10 minutes.
Statistical Analysis
Power analysis revealed that based on Cohen's estimation of a medium effect size
(f----25), power = 80%, and a = 0.05, 64 subjects were needed for each group, for a total of
128(11). Categorical and continuous data were expressed as frequency (percentage) and
mean + SD. Descriptive statistics were used to summarize all demographic and clinical
characteristics of the participants. Baseline participant characteristics in the two
independent groups were compared using an unpaired t-test for continuous variables and
a chi-square test for categorical variables. For the primary outcome variable i.e., average
number of components of metabolic syndrome, data from the baseline, 6 months, and
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12 months were compared using repeated measure analysis of variance (ANOVA). The
results were presented with the associated 95% confidence interval. Where an overall
group difference was found statistically significant, pair-wise comparisons were made
using the appropriate post-hoc test. All statistical tests were two-sided and the p value
smaller than 0.05 was considered to be statistically significant. All statistical analyses
were done using statistical packages SPSS 19.0 (SPSS Inc. Chicago, IL).
Study Progress
A total of 200 individuals were recruited between March and August of 2010.
These were randomized using random allocation software into two groups, an
intervention and control group. At the 6-month visit, 62 were lost at follow up; 32 of the
intervention and 29 of the control group. Additionally one person died from the latter
group. At the 12-month visit, 31 additional subjects were lost at follow up, 16 and 15 of
the intervention and control group respectively. The following flow chart shows the
overall study progress.
[Insert Figure 4.1 here]
Results
Among those recruited 120 (60%) were men, and 80 (40%) were women. The
number of males was higher in both groups, 58 in the intervention and 62 in the control
groups. All subjects were of the same ethnicity as they were all Qatari nationals. The
mean height for the intervention group was 162.7cm +8.71 (range: 139-182), and for the
control group 162.5cm +9.29 (range: 143-185). Patient demographics, metabolic
syndrome components and anthropometrics are listed in Table 1 below.
[Insert Table 4.1 here]
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Information regarding the number of components of metabolic syndrome among
each group is summarized in table 2 below.
[Insert Table 4.2 here]
The results showed no significant difference over time between the groups in
regard to weight, BMI, waist circumference, glucose, HDL cholesterol, triglycerides,
diastolic, and systolic blood pressure, and the number of metabolic syndrome
components as well as total and LDL cholesterol. The detailed results are presented in
Table 3.
[Insert Table 4.3 here]
NEAT Activity
In regard to the frequency of NEAT practiced, among the 40 participants that did
report their activity, 24 (60%) were found to have practiced NEAT enhancing activities
1-2 times a week, 10 (25%) practiced it 3-4 times a week, and 3 (7.5%) did it more than
4 times a week, while 3 (7.5%) reported no activity.
Discussion
The increasing prevalence of metabolic syndrome in Qatar is just one indication
among many that this population is suffering as a result of major lifestyle changes that
have occurred in the past four decades. In this study on 200 subjects, there was no
significant difference between the groups on the measures of metabolic syndrome after a
1-year intervention study. We are unaware of previous studies using NEAT as an
intervention in patients with metabolic syndrome. Most of the patients were middle aged
or older, and already had established type 2 diabetes. Such interventions may be effective
in younger patients, and work better for prevention rather than cure.

47

Factors that play an important role in the development of metabolic syndrome
include genetics, sedentary lifestyle, cigarette smoking, progressive weight gain, and a
Western diet (12- 13). Lifestyle plays a major role in the etiology of metabolic syndrome
either through low physical activity or excess caloric intake or both. The most common
risk factor seems to be abdominal obesity which majorly justifies lifestyle modification.
The American Heart Association states that "in the long run, the greatest benefit for those
with metabolic syndrome will be derived from effective lifestyle intervention" (14).
Levine et al. (4) show that NEAT plays an important role in overall energy balance
because it may vary as much as 2000 kcal/day between individuals. Moreover, they
indicate that highly active people may expend as much as three times more than inactive
people. In 2006 a study conducted at the Mayo Clinic found that the mean energy
expenditure while seated was approximately 70 kcal/h, in contrast to walking and
working which was about 190 kcal/h, with the mean increase of energy expenditure at
approximately 120 kcal/h. The study concluded that replacing time sitting at the desk by
time walking and working, individuals would lose 20-30 kg per year, if other components
of energy expenditure remained the same
In another study by Levine, the author indicates that when a person walks at
1 mile per hour, instead of sitting, the energy expenditure of a 70 kg person is
approximately 100 kcal/h (16). Levine and Kotz in a third study indicate that obesity is
associated with a predisposition to be seated for a longer period of time in comparison to
more lean individuals (about 160 min/day), and if these individuals used this time to
stand or ambulate they would burn up to 350 kcal/day(17).
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Despite the previously mentioned studies that highlighted the importance and
effectiveness of NEAT in increasing energy expenditure, components of metabolic
syndrome showed no significant difference between the groups in this study. This can be
due to many reasons. Non compliance is one of the major influencing factors, which can
be due to social norms, or lack of local convincing evidence on the effectiveness of
NEAT, or lack of awareness. It appears that not enough NEAT was accomplished per
week to influence the results. It is possible that NEAT should be carried out and practiced
on a daily basis to the point where it becomes a personal habit or part of one's lifestyle
before one might expect to see significant results.
While the results were disappointing they provide a basis for future studies. To
increase NEAT, more significant activities that expend more energy than others may be
emphasized like walking. Furthermore, specific goals to be attained in regard to
frequency and duration of activity should be promoted. Another suggestion would be to
use pedometers or other physical activity sensors as an incentive to increase NEAT as
Gardner and Campagna show that such devices help increase motivation and aid in
raising awareness to different activity patterns 08). Also, self-report was used as a
reporting method, where subjects may tend to over report, or simply forget. Only 40% of
participants in the intervention group filled out the report forms.
Other factors may include the high dropout rate and missing data. To improve the
dropout rate, one may consider shortening the time between follow up visits or by
providing incentives at each visit. Other possible options include increasing the frequency
and type of reminders, such as using phone follow ups on regular basis. Additionally the
quality of training of personnel who gave the advice may be improved, as well as the
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quality of advice given. Additionally, many other factors may have influenced
participants of this study, such as the limited physical activity outlets considering the
overall hot weather, which also contributes to the common sedentary lifestyle, which is
quite prevalent in the area, as well as the occurrence of the month of fasting during the
final evaluation of some participants.
Due to the high rate of metabolic syndrome locally, it would be beneficial to
conduct similar studies as the one here but on a larger scale, to help curb the epidemic of
metabolic syndrome and its hazardous outcome. Such studies should take into
consideration the high dropout rate which occurred in this study, and should be
constructed to minimize such occurrences.
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200 started
100 intervention
group

100 control
group
29 lost to follow up

32 lost to
follow up

1 died
V

6 months: 70

6 months: 68

15 lost to
follow up

16 lost to
follow up
V

V

12 months: 55

12 months: 52

Figure 4.1 Flow chart showing study progress
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Variable

Intervention

Control

p-value*

Gender
Male
Female

(n=100)
58 (58%)
42 (42%)

(n=10
62 (62%)
38 (38%)

0.564

•Age (years)
Mean ± SD
Median (Range)

(n=100)
57.1±13.44
56.5 (20-84)

(n=100)
55.9±12.32
57.5 (18-85)

0.490

Marital Status
Married
Single
Widowed
Divorced

(n=100)
83 (83.0%)
9(9.0%)
7 (7.0%)
1 (1,0%)

(n=100)
88(88.0%)
10(10.0%)
1 (1.0%)
1 (1.0%)

Height (cm)
Mean ± SD
Median (Range)

(n=100)
162.7±8.71
162.0(139-182)

(n=100)
162.3±9.29
161.0(143-185)

Weight (kg)
Mean ± SD

(n=100)
86.9±18.48

(n=100)
87.0±19.25

0.952

BMI (kg/m')
Mean ± SD

(n=100)
33.0±7.04

(n=100)
33.1±7.66

0.935

(n=100)
108.2±12.26

(n=100)
108.4±14.13

0.902

Glucose (mmol/L)
Mean ± SD

(n=94)
8.4±3.15

(n=93)
8.5±3.5

0.762

High-density lipoprotein cholesterol
(mmol/L)
Mean ± SD

(n=92)
1.1±0.28

(n=94)
1.1±0.35

0.595

Low-density lipoprotein cholesterol
(mmol/L)
Mean ± SD

(n=92)
2.7±0.94

(n=94)
2.7±0.89

0.872

Triglyceride (mmol/L) •
Mean ± SD

(n=92)
1.6±0.94

(n=94)
1.6±1.1

Cholesterol (mmol/L)
Mean ± SD

(n=92)
4.6±1.1

(n=93)
4.6±1.0

0.965

Systolic blood pressure (mmHg)
Mean ± SD

(n=100)
145.1±18.51

(n=99)
140.5±20.18

0.096

Diastolic blood pressure (mmHg)
Mean ±. SD

(n=100)
76.8±10.65

(n=99)
76.3±10.77

0.744

(n=90)

(n=88)

65 (72.2%)
25 (27.8%)

64 (72.7%)
24 (27.3%)

0.940

62 (68.9%)
28 (31.1%)

62 (70.5%)
26(29.5%)

0.820

69 (76.7%)
21 (23.3?/o)

66 (75.0%)
22 (25.0%)

0.795

Waist circumference (cm)
Mean ± SD

0.195

0.772

,

0.970

Medications
Anti-diabetic
Yes
No
Lipid-lowering
Yes
• No
Anti-hypertensive
Yes
No

Table 4.1 Patient demographics, metabolic syndrome components, and anthropometrics (Quantitative values expressed as mean ± SD/
p-value derived using independent Mest, qualitative values expressed as number (percentage)/p-value derived using chi square test).
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Components of
metabolic syndrome

Intervention

Control

Elevated waist
circumference
Yes
No

(n=100)
95 (95.0%)
5 (5.0%)

(n=100)
92 (92.0%)
8 (8.0%)

0.390

Elevated triglycerides
Yes
No

(n=94)
63 (67.0%)
31(33.0%)

(n=98)
63(64.3%)
35(35.7%)

0.690

Elevated blood pressure
Yes
No

(n=100)
91(91.0%)
9(9.0%)

(n=99)
88(88.9%)
11(11.1%)

0.620

Reduced HDL cholesterol
Yes
No

(n=94)
70 (74.5%)
24 (25.5%)

(n=96)
80 (83.3%)
16(16.7%)

0.134

Elevated glucose
Yes
No

(n=97)
86 (88.7%)
11(11.3%)

(n=96)
82 (85.4%)
14 (14.6%)

0.502

Table 4.2 Patients' metabolic syndrome components (p-value derived using_ chi square test).
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P value

Time Points
Baseline
(Mean + SD)

6 months
(Mean + SD)

12 months
(Mean ± SD)

p-value*

Intervention (n=48)
Control (n=49)

84.2+18.51
86.5+20.19

84.6+18.46
85.9+20.34

84.9+19.16
86.3+21.23

0.677

Body mass index (kg/m')
Intervention (n=47)
Control (n=49)

32.15+7.62
33.21+8.32

32.26+7.42
32.99+8.37

32.38+7.74
33.12+8.77

0.611

Waist circumference (cm)
Intervention (n=40)
Control (n=47)

104.5+13.21
108.5+13.21

104.6+11.38
108.1+13.24

104.6+11.44
108.4+13.38

0.159

Intervention (n=45)
Control (n=39)

8.78+3.54
9.42+3.93

8.86+3.83
9.29+4.42

8.62+3.47
9.09+4.33

0.501

High-density lipoprotein cholesterol
(mmol/L)
Intervention (n=43)
Control (n=38)

1.14+0.29
1.05+0.31

1.10±0.25
1.03+0.28

1.15+0.28
1.15+0.51

0.396

Low-density lipoprotein cholesterol
(mmol/L)
Intervention (n=43)
Control (n=39)

2.57+0.81
2.53+0.79

2.63+0.71
2.56+0.70

2.58+0.68
2.58+1.05

0.789

Triglyceride (mmol/L)
Intervention (n=43)
Control (n=39)

1.64+0.93
1.79+1.45

1.47+0.68
2.02+1.66

1.51+0.65
1.87+1.35

0.124

Cholesterol (mmol/L)
Intervention (n=43)
Control (n=39)

4.55+0.90
4.41+1.09

4.40+0.73
4.45+0.82

4.38+0.82
4.54+1.42

0.889

Systolic blood pressure (mmHg)
Intervention (n=43)
Control (n=46)

144.77+19.60
142.07+19.94

137.49+18.76
143.59+18.82

137.21+16.64
141.24+19.19

0.456

Diastolic blood pressure (mmHg)
Intervention (n=43)
Control (n=46)

75.79+9.03
75.70+11.76

75.12+9.39
78.22+10.81

72.72+9.46
76.15+10.43

0.218

Number of components of metabolic
- syndrome
Intervention (n=50)
Control (n=45)

3.64+0.77
3.98+0.78

3.68+0.79
3.96+0.85

3.78+0.76
4102+0.86

0.059

Variable

Weight (kg)

Glucose (mmol/L)

Table 4.3 Comparison of anthropometrie and metabolic parameters at baseline, 6 months, and 12 months in completers in the
intervention and control group (p-value derived usin9, repeated measures ANOVA test).
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CHAPTER 5
ADDITIONAL DATA

A. Background
In this proof of concept study, there were no differences in metabolic syndrome
components between groups randomized to the NEAT or control interventions. In order
to clarify whether certain subgroups showed changes in parameters following the
intervention, we compared results in the intervention and control groups among
individuals with diagnosed diabetes, among males and females separately, and among
subjects that reported the amount of NEAT performed. Finally we looked at baseline
characteristics of completers versus non-completers of the study to better understand
characteristics associated with compliance.
B. Results in Individuals Using Anti-Diabetic Medications
Physical activity in general and NEAT in specific benefit diabetic individuals
through improving their sensitivity to insulin therefore reducing their risk for CVD. Sigal
(2006) indicates that exercise for two months or more is significantly effective in
reducing HbAl c in patients with type 2 diabetes. This section had two goals, (a) to look
at the risk level of those using anti-diabetic medications versus their counterparts not
taking medications, and (b) to examine if results in those on anti-diabetics differed from
the whole 'group (because of their higher risk level).
In this study, 72.2% of the intervention groups were using anti-diabetic
medication, while 27.8% were not. For the control group 72.7% were using anti-diabetic
medication, while 27.3% were not. To compare risk factors among those on anti diabetic
mediations and those not on medications, we ran a chi square test on the 5 components of
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metabolic syndrome. Not surprisingly, as shown in the table below almost all those on
anti-diabetic medication fulfilled the high glucose criterion of metabolic syndrome. In
addition subjects on anti-diabetic medication were more likely to meet the low HDL
cholesterol criterion of metabolic syndrome than their counterparts.
Table 5.1 Percentages of Risk Factors Among Those Using and Not Using Anti Diabetic
Medications (p-value derived using chi square test)
Components of metabolic
syndrome

On anti diabetic
medications

Not on anti diabetic
medications

p-value

120(93.0%)
9 (7.0%)

47(95.9%)
2 (4.1%)

0.474

91 (72.0%)
35 (27.8%)

29(59:3%)
20 (40.8%)

0.950

116(90.6%)
12(9.4%)

45 (91.8%)
4 (8.2%)

0.801

108 (85.0%)
19(15.0%)

33 (71.7%)
13(28.3%)

0.047

128(99.2%)
1 (8.0%)

29 (63%)
17(37%)

0.000

Elevated waist circumference
(n=178)

Yes
No
Elevated triglycerides (n=175)
Yes
No
Elevated blood pressure
(n=177)

Yes
No
Reduced HDL cholesterol
(n=173)

Yes
No
Elevated glucose
(n=175)

Yes
No

C. Comparison Between Groups
When looking at those participants that were treated with anti diabetic
medications alone in the NEAT intervention versus the control group, upon analyzing the
results using, a repeated measures ANOVA test; there was no significant difference over
time between the groups in regard to weight, BMI, waist circumference, glucose, HDL
cholesterol, triglycerides, diastolic and systolic blood pressure, as well as total and LDL
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cholesterol and the number of metabolic syndrome components. The table below
summarizes the results.
Table 5.2 Comparison of Anthropometric and Metabolic Parameters at Baseline, 6
Months, and 12 Months in Completers in the Intervention and Control Group Among
Those on- Anti-diabetic.Medication (p-value derived using repeated measure ANOVA
test)
Time Points
Variable

Baseline
(Mean ± SD)

6 months
(Mean ± SD)

12 months
(Mean ± SD)

p-value*

82.0±15.79
82.3±16.38

82.4±15.65
81.5±16.81

82.5±15.98
81.5±16.98

0.888

Body mass index (kg/m2)
Intervention(n37)
Control(n33)

31.0±6.34
33.2±6.03

31.2±6.09
30.9±6.31

31.2±6.27
30.9±6.46

0.933

Waist circumference (cm)
Intervention(n32)
Control(n=31)

103.3±11.86
106.9±12.90

103.4±11.81
106.6±12.87

103.4±11.92
106.7±12.98

Intervention(n35)
Control(n=31)

9.64±3.52
10.37±3.85

9.59±3.84
10.23±4.46

9.44±3.42
9.79±4.58

High-density lipoprotein cholesterol
(mmol/L)
Intervention (n=35)
Control(n=30)

1.12±0.26
1.05±0.33

1.09±0.22
1.03+0.28

1.14±0.27
1.19±0.56

0.709

Low-density lipoprotein cholesterol
(mmol/L)
Intervention (n=35)
Control(n=30)

2.54±0.87
2.37±0.76

2.61±0.73
2.48±0.71

2.49±0.67
2.55±1.15

0.627

Triglyceride (mmol/L)
Intervention (n=35)
Control(n=30)

1.69±1.00
1 85±1 64

1.48±0.67
2.05±1.84

1.49±0.65
1.93±1.51

0.166

Cholesterol (mmol/L)
Intervention (n=35)
Control(n=31)

4 53±0.96
4 31±1.15

4.36±0.75
4.39±0.86

4.26±0.81
4.59±I.55

0.835

Systolic blood pressure (mmHg)
Intervention (n=36)
Control(n=32)

146.00±20.83
141.50±21.84

138.83±19.61
142.88±20.51

138.89±17.23
139.69±19.91

0.978

Diastolic blood pressure (mmHg)
Intervention (n=36)
Control(n=32)

75.25±9.19
75.44±10.14

75.42±9.88
76.69±10.86

72.64±9.69
74.25±10.05

0.603

Number of components of NIS
Intervention (n=39)
Control(n=36)

3.69±0.83
4.00±0.75

3.79±0.80
4.00±0.86

3.82±0.75
4.06±0.86

0.143

Weight (kg)

Intervention(n=37)
Control(n=33)

0.291

Glucose (mmol/L)

0.489
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D. Results by Gender
The results of comparing the groups over time, for males only, showed no
difference for all variables except for the number of metabolic syndrome components
which shows a significant increase in the intervention group while there is a tendency
toward lowering of triglycerides in males in the intervention group. None of the risk
factors were numerically worsened in the males in the intervention group, but as the
definition of metabolic syndrome is based on medications used, not only on blood test
values, that may be the explanation of this result. The results of an analysis using a
repeated measure ANOVA test, on males alone, is listed in Table 5.3.
Table 5.3 Comparison of Anthropometric and Metabolic Parameters at Baseline,
6 Months, and 12 Months in Completers in the Intervention and Control Group Among
Males (p-value derived using repeated measure ANOVA test)
Time Points
Variable
Weight (kg)

Intervention (n=26)
Control (n=29)

Baseline
(Mean SD)

6 months
(Mean ± SD)

12 months
(Mean ± SD)

p-value

83.04+14.69
85.31+18.30

83.90+14.78
84.78+18.89

83.92+15.23
85.28+19.31

0.746

28.98+4.72
30.29+5.19

29.32+4.79
30.09+5.47

29.31+4.98
30.33+5.80

0.467

104.17+9.70
105.85+12.51

104.42+9.82
105.69+12.62

104.37+9.87
105.85+12.66

0.645

9.69+4.12
9.05+3.51

8.8+3.94
9.4+4.84

9.14+3.87
9.62+4.88

0.892

1.08+0.25
0.99+0.30

1.05+0.24
0.99+0.28

1.09+0.24
1.12+0.58

0.599

2.71+0.87
2.56+0.85

2.78+0.81
2.54+0.68

2.74+0.68
2.53+1.10

0.298

I 56+1 04
I 96+1 71

1.35+0.71
2.28+1.93

1.43+0.58
2.02+1.58

0.060

4.63+0.97
4.50+1.21

4.46+0.81
4.50+0.80

4.49+0.89
4.56+1.51

0977

Body mass index (kg/m2)
Intervention (n=25)
Control (n=29)

Waist circumference (cm)
Intervention (n=24)
Control (n=27)

Glucose (mmol/L)
Intervention (n=24)
Control (n=26)

High-density lipoprotein
cholesterol (mmol/L)
Intervention (11=25)
Control (n=27)

Low-density lipoprotein
cholesterol (mmol/L)
Intervention (n=25)
Control (n=27)

Triglyceride (mmol/L)
Intervention (n=25)
Control (n=27)

Cholesterol (mmol/L)
Intervention (n=25)
Control (n=28)
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Table 5.3—Continued.
Time Points
Variable
Systolic blood pressure
(mmHg)
Intervention (n=23)
Control (n=27)

Diastolic blood pressure
(mmHg)
Intervention (n=23)
Control (n=27)

Baseline
(Mean ± SD)

6 months
(Mean ± SD)

12 months
(Mean ± SD)

p-value

142.78+18
142+19.75

136.61+19.22
142.44+19.79

140.26+18.23
141.11+19.20

0.666

75.74+9.21
76.44+10.60

76.57+9.57
79.22+11.34

75.52+10.19
76.96+9.52

0.491

3.57+0.77
4.14+0.75

3.63+0.76
4.18+0.77

3.80+0.76
4.18+0.72

0.007

Number of components of MS
Intervention (n=30)
Control (n=28)

As for females, the results of comparing the groups over time, show no difference
for all variables between the intervention and control groups. The results of an analysis
using a repeated measure ANOVA test, on females alone, is listed in Table 5.4 below.

Table 5.4 Comparison of Anthropometric and Metabolic Parameters at Baseline,
6 Months, and 12 Months in Completers in the Intervention and Control Among Males
(p-value derived using repeated measure ANOVA test)
Time Points
Variable

Weight (kg)

Intervention(n22)
Control(n=20)

Baseline
(Mean ± SD)

6 months
(Mean ± SD)

12 months
(Mean ± SD)

p-value

85.73+22.50
. 88.25+23.04

85.44+22.38
87.65+22.68

86.5+23.29
87.8+24.18

0.762

35.76+8.72
37.44+10.18

35.61+8.51
37.20+10.07

35.88+8.87
37.17+10.75

0.608

105.06+13.91
112.20+13.56

104.94+13.74
111.57+13.62

104.94+13.81
111.90+13.85

0.143

7.74+2.41
10.16+4.74

8.94+3.8
9.07+3.6

8.04+2.95
8.01+2.83

0.402

1.23+0.34
1.21+0.29

1.17+0.25
1.13+0.24

1.24+0.32
1.23+0.30

0 819

2.39+0 77
2.46+0.67

2.43+0.47
2.61+0.79

2.35+0.53
2.69+0.98

0.388

Body mass index (kg/m2)
Intervention(n=22)
Control(n=20)

Waist circumference (cm)
Intervention(n=16)
Control(n=20)

Glucose (mmol/L)
Intervention(n=21)
Control(n=13)

High-density lipoprotein
cholesterol (mmol/L)
Intervention (n=18)
Control(n=11)

Low-density lipoprotein
cholesterol (mmol/L)
Intervention (n=18)
Control (n=12)
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Table 5.4—Continued.
Variable

Baseline
(Mean ± SD)

6 months
(Mean ± SD)

12 months
(Mean ± SD)

p-value

1.75+0.76
1.42+0.40

1.64+0.61
1.43+0.45

1.61+0.75
1.52+0.47

0.319

4.43±0.79
4.19+0.71

4.31+0.62
'4.30+0.90

4.23+0.70
4.51+1.20

0.972

147.05+21.52
142.16+20:75

138.50+18.67
145.21+17.75

133.70+14.26
141.48+19.71

0.526

75.85+9.06
74.63+13.47

73.45+9.13
76.79+10.13

69.5+7.55
75.0+11.78

0.337

3.75+0.78
3.71+0.77

3.75+0.85
3.59+0.87

3.75+0.78
3.76+1.03

0.803

Triglyceride (mmol/L)
Intervention (n=18)
Control (n=12)

Cholesterol (mmol/L)
Intervention (n=18)
Control (n=11)

Systolic blood pressure
Intervention (n=20)
(mmHg)
Control (n=19)

Diastolic blood pressure
(mmHg)
Intervention (n=20)
Control (n=19)

Number of components of
Intervention (n=20)
MS
Control (n=17)

E. Subjects Reporting NEAT Versus Not Reporting NEAT in the
Intervention Group
As for those that did report their NEAT activity; we ran a separate analysis
comparing these participants alone, on the different variables used previously using a
paired t test comparing baseline and 6 months, and baseline and 12 months, to examine
whether or not their NEAT activity modified their metabolic syndrome components. The
results showed no difference for all variables between baseline and 6 months and baseline
and 12 months. The results are shown in Table 5.5.
Table 5.5 Comparison of Anthropometric and Metabolic Parameters Among Those That
Did Report Their NEAT (p-value derived using a paired t-test)
Mean

Variable
Weight (kg)
baseline vs. 6 months (n=29)
baseline vs. 12 months (n=22)
Body mass index (kg/m')
baseline vs. 6 months (n=29)
baseline vs. 12 months (n=22)
Waist circumference (cm)
baseline vs. 6 months (n=28)
baseline vs. 12 months (n=19)
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p-value

89.90

90.28

.312

86.41

87.18

.209

33.42

33.56

.306

32.66

32.93

.286

108.93

109.00

.663

107.47

107.63

.506

Table 5.5-Continued.
Glucose (mmol/L)
baseline vs. 6 months (n=30)

9.07

8.36

.148

9.09

9.03

.918

1.140

1.06

.333

1.250

1.20

.278

2.68

2.56

.399

2.73

2.54

.267

1.84

1.61

.158

1.66

1.50

.474

4.50

4.35

.469

4.75

4.42

.063

148.75

140.93

.062

146.00

139.09

.142

78.43

76.18

.275

baseline vs. 12 months (n=22)

76.86

75.45

.595

Number of components on metabolic syndrome
baseline vs. 6 months (n=32)

3.63

3.75

.255

baseline vs.12 months (n=22)

3.55

3.59

.576

baseline vs. 12 months (n=23)
High density lipoprotein cholesterol (mmol/L)
baseline vs. 6 months (n=29)
baseline vs. 12 months (n=20)
Low density lipoprotein cholesterol (mmol/L)
baseline vs. 6 months (n=29)
baseline vs. 12 months (n=20)
Triglycerides (mmol/L)
baseline vs. 6 months (n=29)
baseline vs. 12 months (n=20)
Cholesterol (mmol/L)
baseline vs. 6 months (n=29)
baseline vs. 12 months (n=20)
Systolic blood pressure (mmHg)
baseline vs. 6 months (n=28)
baseline vs. 12 months (n=22)
Diastolic blood pressure (mmHg)
baseline vs. 6 months (n=28)

F. Characteristics of Completers Versus Non-completers
Since the characteristics of completers might be different than non-completers, we
ran a separate analysis using an independent t test to explore baseline metabolic
parameters and other anthropometric measurements between the two groups. The
analysis revealed that mean LDL cholesterol and total cholesterol levels were statistically
significantly different between groups. It was observed that that mean LDL cholesterol
and total cholesterol levels were significantly higher among non-completers than
completers. Additionally, the results indicate that more men than women were noncompleters (66% of non-completers versus 54.2% of completers). These results may
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become useful to future researchers when deciding on their study populations. The results
are summarized in Table 5.6.
Table 5.6 Comparison of Anthropometric and Metabolic Parameters Among Completers
and Non-completers (p-value derived using independent t-test)
Variable

Completers

Non-completers

p-value

Gender
Male
Female

(n=107)
58 (54.2%)
49(45.8%)

(n=93)
62 (66.7%)
31(33.3%)

0.073

Height (cm)
Mean 1 SD

(n=107)
162.0+9.19

(n=93)
163.2+8.74

0.349

Weight (kg)
Mean ± SD

(n=107)
85.6+18.70

(n=93)
88.5+18.93

0.263

BMI (kg/m2)
Mean ± SD

(n=107)
32.8+7.74

(n=93)
33.3+6.89

0.649

(n=107)
107.2+11.89

(n=93)
109.5+14.53

0.219

Glucose (mmol/L)
Mean ± SD

(n=106)
8.6+3.56

(n=81)
8.3+3.08

0.541

High-density lipoprotein cholesterol
(mmol/L)
Mean ± SD

(n=105)
1.1+0.31

(n=81)
1.1+0.33

0.971

Low-density lipoprotein cholesterol
(mmol/L)
Mean ± SD

(n=105)
2.5+0.83

(n=81)
2.9+0.96

0.002

Triglyceride (mmol/L)
Mean ± SD

(n=105)
1.6+1.19

(n=8I)
1.6+0.83

0.576

Cholesterol (mmol/L)
Mean ± SD

(n=105)
4.4+0.99

(n=80)
4.8+1.10

0.008

Systolic blood pressure (mmHg)
Mean ± SD

(n=107)
141.9+19.32

(n=92)
143.8+19.66

0.496

Diastolic blood pressure (mmHg)
Mean ± SD

(n=107)
75.31+10.45

(n=92)
78.0+10.83

0.070

(n=105)
3.72+0.83

(n=89)
3.75+0.69

0.796

(n=102)

(n=76)

76 (74.5%)
26 (25.5%)

53 (69.7%)
23(30.3%)

0.481

68 (66.7%)
34 (33.3%)

- 56 (73.7%)
20 (26.3%)

0.314

77 (75.5%)
25 (24.5%)

58 (76.3%)
18(23.7%)

0.899

Waist circumference (cm)
Mean ± SD

Components of metabolic syndrome
Mean ± SD
Medications
Anti-diabetic
Yes
No
Lipid-lowering
Yes
No
Anti-hypertensive
Yes
No
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G. Conclusion
This study looked into whether or not giving advice to increase daily NEAT
would influence metabolic markers in participants. The theoretical framework suggested
that since NEAT is part of human energy expenditure, then increasing NEAT throughout
the day would increase energy expenditure among metabolic syndrome patients, thus
improving their metabolic markers, and in turn positively adjusting their risk of CVD.
Giving advice to increase daily NEAT showed no significant effects on metabolic
syndrome components in this study. These additional analyses looking at subgroups of
study individuals also found no significant differences between groups according to use
of anti-diabetic medication or gender (with the exception that the number of metabolic
syndrome components seemed to increase in men in the intervention group). In addition,
subjects that reported NEAT did not differ in their results from subjects that did not
report NEAT. Finally, non-completers tended to be males, and had higher total and LDL
cholesterol levels than completers. Future researchers might build on this study by
conducting studies in a shorter period of time, using more efficient follow up methods;
like increasing the frequency of follow up visits, or by providing incentives to
• participants at each visit. Additionally, the main concept of the study may be studied
using a higher level and better controlled intervention.
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CHAPTER 6
CONCLUSIONS

The results of the study show no significant difference in metabolic syndrome
parameters between the group that received advice to practice NEAT and the control
group. These results also apply to comparisons made between those on anti diabetic
medications and those that are not on anti diabetic medications. Additionally, they also
apply for comparisons made between genders.
The concept of the study originated during one of Dr. Tonstad's classes which
was titled "Obesity and Disordered Eating," during which the concept of NEAT was
covered as a method of increasing energy expenditure among obese individuals. I further
researched the topic to find it used in several of Levine's studies. After deciding on doing
this study in Qatar, I looked into what disease should be chosen and realized that the
country had high numbers of obesity and diabetes. Therefore I decided to go with
metabolic syndrome as it includes both an overweight and increased glucose aspect.
Conducting this study in all its steps and stages was a good learning experience,
as I had the chance to be exposed to the different aspects of a study, starting from the
process of planning the different steps of it, obtaining IRB approval, collecting the data,
analyzing, and interpreting it. All these were the principles that I learned theoretically in
the classroom through classes taken during the course of my studies. But doing it in
person brought things into perspective, and a lot of information learned took place in
reality.
One of the more pleasurable parts of the study was interaction with patients which
was a rich learning experience. Reflecting on some of the conversations I had with some
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of the participants, I learned that people in Qatar have certain restrictions prohibiting
them from exercising in what can be considered as conclusive reasons that exist in such a
culture. During one conversation with one of the participants, she indicated that the major
factor behind her failure to exercise was the presence of non-family members in their
house yard, such as the driver or other house help that commonly work in homes of
Qataris, in many cases not out of necessity but rather as a cultural norm.
On the other hand, another participant expressed that she was pleased with this
method of increasing energy expenditure, referring to NEAT, and said she finds it to be
an easy and accessible method to do so. She now used the stairs whenever visiting her
doctor, occasionally asks her driver to park further down the parking lot, when weather
permits so. Additionally she tries to walk around the house for a few minutes each day,
and takes the longer route to things that are within house limits, like when going to the
kitchen or trying to reach the living room.
On a different aspect I find several areas of the study that are worth improving or
changing. First example is the setting of the study, had it allowed us to include younger
participants, rather than older participants with established disease - about three-fourths
of the subjects were treated with anti-diabetic medication. Furthermore, all of the
participants were of the same ethnicity, limiting generalizability.
Another item is related to health education and raising awareness to the negative
aspect of metabolic syndrome and the positive aspects of the concept of NEAT. Had the
participants been scheduled for monthly visits with a health educator to highlight the
previously mentioned points, it would have possibly helped some participants in realizing
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the risks associated with the disease along with the benefits of NEAT and increased their
motivation for change.
In all, the concept of NEAT as shown in literature through Levine's studies was a
feasible approach to recruitment of subjects. 200 subjects were recruited and followed up
within a short period of time. Thanks to my advisors and staff at the hospital for
facilitating this study. Though the results were disappointing, future efforts should
probably be focused on creating new approaches to increasing NEAT among high risk
patients.

68

REFERENCES
Alberti, K., Eckel, R., Grundy, S., Zimmet, P., Cleeman, J., Donato, K., Fruchart, J.,
Loria, C., & Smith, S. (2009). Harmonizing the metabolic syndrome: A joint
statement of the International Diabetes Federation Task Force on Epidemiology
and Prevention; National Heart, Lung, and Blood Institute; American Heart
Association; World Heart Federation; International Atherosclerosis Society; and
International Association for the Study of Obesity. Journal of the American heart
association, 120, 1640-1645.
Arrol, B., & Beaglehole, R. (1992). Does physical activty lower blood pressure: A critical
review of clinical trials. Journal of Clinical Epidemiology, 45, 439-447.
Al-Sarraj, T., Saadi, H., Volek, J. S., & Fernandez, M. L. (2010). Metabolic syndrome
prevalence, dietary intake, and cardiovascular risk profile among overweight and
obese adults 18-50 years old from the United Arab Emirates. Metabolic Syndrome
and Related Disorders, 8, 39-46.
Bener, A., Zirie, M., & Al-Rikabi, A. (2005). Genetics, obesity, and environmental risk
factors associated with type 2 diabetes. Croatian Medical Journal, 46, 302-307.
Bener, A., & Tewfik, I. (2006). Prevalence of overweight, obesity, and associated
psychological problems in Qatari's female population. Obesity Reviews, 7, 139145.
Bener, A., Zirie M., Musallam, M., Khader, Y. S., & Al-Hamaq, A. 0. (2009).
Prevalence of metabolic syndrome according to adult treatment panel III and
international diabetes federation criteria. Metabolic Syndrome and Related
Disorders, 7, 221-230.
Cone, J. D., & Foster, S. L. (2006). Dissertations and theses from start to finish (2nd Ed.).
Washington, DC: American Psychological Association.
Cohen, J. (1992). A power primer. Psychological Bulletin, 112, 155-159.
Ervin, R. (2009). Prevalence of metabolic syndrome among adults 20 years of age and
over, by sex, age, race and ethnicity, and body mass index: United States, 20032006. National Health Statistics Reports, 13,1.
Fan, A. (2007). Etiology of the metabolic syndrome. Current Cardiology Reviews, 3,
232-239.
Fox, K., & Hillsdon, M. (2007). Physical activity and obesity. Obesity Reviews, 8, 115121. -

69

Ford, E., Kohl, H., Mokdad, A., & Ajani, U. (2005). Sedentary behaviour, physical
activty, and the metabolic syndrome among US adults. Obesity Research, 13,
608-614.
Gardner, P., & Campagna, P. (2011). Pedometers as measurement tools and motivation
devices: New insights for researchers and practitioners. Health Promotion
Practice, 12, 55-62.
Gutierrez, J., & Fletcher, G. (2007). Impact of exercise on blood lipids and lipoproteins.
Journal of Clinical Lipidology, 1, 175-181.
Grundy, S., Cleeman, J., Daniels, S., Robert, E., Franklin, B., Gordon, D., Donato, K.,
Krauss, R., Savage, P., Smith, S., & Costa, F. (2005). Diagnosis and management
of the metabolic syndrome: An American Heart Association/National Heart,
Lung, and Blood Institute scientific statement. Circulation, 112, 2735-2752.
Gordon, L. Morrison, E., McGrowder, D., Young, R., Terry, Y., Zamora, E., Lindo, R., &
Irving, R. (2008). Effect of exercise therapy on lipid profile and oxidative stress
indicators in patients with type 2 diabetes. BMC Complementary and Alternative
Medicine, 8, 21.
Harvey, R., & Ferrier, D. (2008). Biochemistry, Lippincott's illustrated reviews.
Baltimore, MD: Wolters Kluwer.
Huang, IC., Kormas, N., Loughnan, G., & Caterson, I. (2004). Resting metabolic rate in
severely obese diabetic and nondiabetic subjects. Obesity Research, 12, 840-845.
Healy, G., Dunstan, D., Salmon, J., Cerin, E., Shaw, J., Zimmet, P., & Owen, N. (2007).
Objectively measured light intensity physical activty is independantly asscoited
with 2 h plasma glucose. Diabetes Journal, 30, 1384-1389.
Isomaa, B., Almgren, P., Tuomi, T., Forsen, B., Lahti, K., Nissen, M., Taskinen, M. R.,
& Groop. L. (2001). Cardiovascular morbidity and mortality associated with the
metabolic syndrome. Diabetes Care, 24, 683.
International diabetes federation (2006). The IDF consensus worldwide definition of the
metabolic syndrome. Retrieved from
http://wwwidf. org/webdata/docs/IDF_Meta_def final.pdf
Kelley, G., & Kelley, K. (2007). Effects of aerobic exercise on lipids and lipoproteins in
adults with type 2 diabetes. Public Health, 121, 643-655.
Kraus, W., & Slentz, C. (2009). Exercise training, lipid regulation, and insulin action:
A tangled web of cause and effect. Obesity, 17, 21-26..

70

Kravitz, L., & Heyward, V. (2011). The exercise and cholesterol controversy. Retrieved
from http://www.unm.edu/-1kravitz/Article%20folder/cho1esterol.html
Kushner, R., & Bessesen, D. (2007). Treatment of the obese patient. Totawa, NJ:
Humana Press.
Laaksonen, D., Lakka, H., Salonen, J., Niskanen, L., Rauramma, R., & Lakka, T. (2002).
Low levels of leisure time physical activity and cardiorespiratory fitness predict
development of the metabolic syndrome. Diabetes Care, 25, 1612-1618.
Lanningham, L., Nysse, L., & Levine, J. (2003). Labor saved, calories lost: The energetic
impact of domestic labor saving devices. Obesity Research, 11,1178-1181.
Levine, J., Eberhardt, N., & Jensen, M. (1999). Role of non-exercise activity
thermogenesis in resistance to fat gain in humans. Science, 283, 212.
Levine, J. A., & Kotz, C. M. (2005). NEAT-non-exercise activity thermogenesis.
egocentric and geocentric environmental factors vs. biological regulation. Ada
Physiologica Scandinavica, 184, 309-318.
Levine, J. A. (2007). Non-exercise activity thermogenesis: Liberating the life-force.
Journal of Internal Medicine, 262, 273-287.
Levine, A., & Miller, J. (2007). The energy expenditure of using a walk and work desk
for office workers with obesity. British Journal of Sports Medicine, 41, 558-561.
Levine, J., VanderWeg, M. W., Hill, J., & Klesges, R. (2006). Non exercise activity
thermogenesis: The crouching tiger hidden dragon of societal weight gain.
Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 729-736.
Levine, J., Yeager, S. (2009). Mova a little, lose a lot: The NEAT science reveals how to
be thinner, happier, and smarter. Retrieved from http://www.usatoday.com/news
/health/weightloss/2009-01-21-fidget-activity_N.htm
Kerrie, M., Rachel, D., Jason, L., Colleen, M., Edward, H., Bassett, D., & Dixie, T.
(2001) Increasing daily walking lowers blood pressure in postmenopausal women.
Medicine and Science in Sports and Exercise, 33, 1825-1831.
Marrugat, J., Elosua, R., Covas, M., Molina, L., & Prat, J. (1996). Amount and intensity
of physical activity, physical fitness, and serum lipids in men. American Journal
of Epidimiology, 143, 562-569.
Mayo Clinic. (2009). Metabolic syndrome risk factors. Retrieved from
http://www.mayoclinic.com/health/metabolic%20syndrome/DS00522
/DSECTION —risk-factors

71

Mayo Clinic. (2011). High blood pressure. Retrieved from
http://www.mayoclinic.com/health/hiQh-blood-pressure/HI00024
Metabolic Syndrome Institute. (2010). Cardiovascular morbidity and mortality associated
with the metabolic syndrome. Retrieved from http://www.metabolic-syndromeinstitute.org/informations/prognosis-outcomes/cardiovascular-morbidity-andmortality-associated-with-the-metabolicsyndrome.php?PHPSESSID----83fcf8da0c99560826b9dfeb3c6aebb3
Meigs J. (2002). Epidemiology of the metabolic syndrome. The American Journal of
Managed Care, 8, 283-292.
Meigs J. (2003). The metabolic syndrome. British Medical Journal, 327, 61.
Meigs, J. (2004). The metabolic syndrome (insulin resistance syndrome or syndrome X).
Retrieved from http://www.uptodate.com/contents/the-metabolic-syndromeinsulin-resistance-syndrome-or-syndromex?source=search_result&search—metabolic+syndrome&selectedTitl e=1-150
Mokan, M., Galaida, P., Pridavkova, D., Tomaskova, V., Sutarik, L., Krucinska, L.,
Bukovska, A., & Rusnakova, G. (2008). Prevalence of diabetes mellitus and
metabolic syndrome in Slovakia. Diabetes Research Clinical Practice, 81, 238242.
Minich, D., & Bland, J. (2008). Dietary management of the metabolic syndrome beyond
macronutrients. Nutrition Reviews, 66, 429-444.
Musallam, M., Bener, A., Zirie, M., Al-Gaud, Y. K., Al-Hamaq, A., Othman, M. A., &
Tewfik, I. (2008). Metabolic syndrome and its components among Qatari
population. International Journal Food Safety, Nutrition and Public Health, 1,
88-102.
Novak, C., & Levine, J. (2007). Central neural and endocrine mechanisms of non
exercise activity thermogenesis and their potential impact on obesity. Journal of
Neuroendocrinology, 19, 923-940.
National institute of child health and human development (NICHD). Non-exercise
activity thermogenesis (NEAT) in children (2008). Retrieved from
http://clinicaltrials.gov/ct2/show/record/NCT00315172
Pitsavos, C, Panagiotakos, D., Chrysohoou, C., Papaioannou, I., Tousoulis, D., &
Stefanadis, C. (2003). The adoption of Mediterranean diet attenuates the
development of acute coronary syndromes in people with the metabolic
syndrome. Nutrition Journal, 2,1.

72

Padilla, J., Wallace, J., & Park, S. (2005). Accumulation of physical activity reduces
blood pressure in pre and hypertension. Medicine and Science in Sports and
Exercise, 37, 1264-1275.
Ravussin, E., Burnard, B., Schutz, Y., & Jequier, E. (1982). Twenty-four hour energy
expenditure and resting metabolic rate in obese, moderately obese, and control
subjects. American Journal of Clinical Nutrition, 35, 566-573.
Santos, A., Ebrahim, S., & Ban-os, H. (2008). Gender, socioeconomic status and
metabolic syndrome in middle aged and old adults. BMC Public Health, 8, 62.
Schiltz, B., Minich, D., Lerman, R., Lamb, J., Tripp, M., & Bland, J. (2009). A science
based clinically tested dietary approach for the metabolic syndrome. Metabolic
Syndrome and Related Disorders, 7, 187-192.
Shadish, W. R., Cook, T. D., & Campbell, D. T. (2002). Experimental and quasiexperimental designs for generalized casual inference. Boston: Houghton Mifflin.
Sigal, R., Kenny, G., Wasserman, D., Sceppa, C., & White, R. (2006). Physical activity,
exercise, and type 2 diabetes. Diabetes Care, 29, 1433-1438.
Trainor, K. (2009). Stand up right now. Natural Health, 39, 67-73.
Wei, M., Gibbons, L., Mitchel, T., Kampert, J., Lee, C., & Blair, S. (1999). The
association between cardio respiratory fitness and impaired fasting glucose and
type 2 diabetes mellitus in men. Annals of Internal Medicine, 130, 89-95.
Wilson, J. (2004). Non exercise activity thermogenesis (NEAT). Retrieved from
www.abcbuilding.com/neat.pdf

7_3

APPENDIX A: GANTT CHART SHOWING STUDY TIMELINE

Final
approval
Quest.
design
Data
collection
Data
analysis
Write up
Progress
report
Final
report

Mar
/
Apr
X

May
/
Jun

Jul
/
Aug

Sep
/
Oct

Nov
/
Dec

Jan
/
Feb

Mar
/
Apr

May
/
Jun

Jul
Sep
/
/
Augt
,.,
.

X

X

X

X

X

X

X

X

X
X

X
X
X

X
X

74

APPENDIX B: BUDGET BREAKDOWN

BUDGET CATEGORY
TOTALS
PERSONNEL: Salary and fringe
benefits. Applicant organization
only.
CONSULTANT COSTS

INITIAL BUDGET
2nd ADDITIONAL
3rd ADDITIONAL
PERIOD
YEAR OF SUPPORT YEAR OF SUPPORT 4th YEAR 5th
YEAR
(from Form Page 4)
REQUESTED
REQUESTED

1500
800

EQUIPMENT

50

SUPPLIES

50

TRAVEL
INPATIENT CARE
COSTS
OUTPATIENT CARE
COSTS
ALTERATIONS AND
RENOVATIONS
COMMUNICATION EXPENSES

100

DIRECT CONSORTIUM/
CONTRACTUAL
COSTS
SUBTOTAL DIRECT COSTS
(Sum = Item 8a, Face Page)

2500

i

F&A CONSORTIUM!
CONTRACTUAL
COSTS
TOTAL DIRECT COSTS

2500

TOTAL DIRECT COSTS FOR ENTIRE PROPOSED PROJECT PERIOD
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$

2500

Budget Justification
The budget has five major categories; these are personnel, consultant costs,
equipment, supplies, and communication expenses. Under personnel, a nurse charges
$500, a total of three nurses will participate for a total of $1500. Under consultant costs, a
research assistant charges $800 per study. Under equipment, the educational material to
be given to participants will be purchased in bulk from the health education department at
Hamad General Hospital. The cost for a total of 200 booklets is $50. Under supplies,
office supplies and paper copies cost approximately $50. Under other expenses, the
contracted marketing company charges 25 cents for each text message including a
reminder message of participation. A total of 400 reminders will be sent over a one year
period for the cost of $100. This brings the grand total to $2500.
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APPENDIX C: REPORT SHEET USED IN CURRENT STUDY

Week 1
Day/Date

NEAT Weekly Report Sheet
Stair
climbing
instead
of using
the
elevator

Gum
chewing/
others

Fidgeting
voluntarily

Sunday
Monday
Tuesday
Wednesday
Thursday
Friday
Saturday
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Walking
instead
of
driving

Standing
instead
of sitting

Notes

APPENDIX D: CONSENT FORM IN ENGLISH
MEDICAL RESEARCH CENTRE
HGH • WH •

RH • AAH • AKH •

MR #:

Others s

PATIENT NAME:
DOB:
GENDER:
NATIONALITY:
- LOwi

GENERIC SIGNED CONSENT FORM
You are invited to participate in this study entitled "The effect of non-exercise
activity thermo genesis (NEAT) on weight among Qatari patients
with metabolic syndrome, a randomized controlled study". You are
free to ask as many questions as you like before, during or after in this research,
you decide to give consent to participate in this research study. The information
in this form is only meant to better inform you of all possible risks or benefits.
Your participation in this study is voluntary. You do not have to take part in this
study, and your refusal to participate will involve no penalty or loss of rights to
which you are entitled. You may withdraw from this study at any time without
penalty or loss of rights or other benefits to which you are entitled. The
investigator(s) may stop your participation in this study without your consent for
reasons such as: it will be in your best interest; you do not follow the study plan;
or you experience a study-related injury. Randomization will be carried out by
asking patients to randomly choose from two envelopes that contain the type of
group.
Project title: The effect Non Exercise Activity Thermogenesis (NEAT) on weight
among Qatari subjects with metabolic syndrome; a randomized controlled study.
Name of Principal Investigator:

Dr. Samer Hammoudeh

Location and phone numbers:
Outpatient Department/Endocrinology and Diabetes clinic, Hamad Medical
Corporation

-7007642
- 5546316

Dr. Mahmoud Zirie
Dr. Abdullah Al-Hamaq
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Introduction to the research

Metabolic syndrome is a combination of medical conditions in one person that
increase the risk of that person to develop diabetes as well as diseases of the heart
and blood vessels. Metabolic syndrome is very common that it affects one in five
people, and the chance of getting it increases with age. Persons who suffer from
the metabolic syndrome are usually overweight, stressed, have high blood
pressure, and high fat levels in their blood. In addition, their body cannot use its
insulin, the hormone that is supposed to regulate blood sugar, in a proper way.
Many treatments have been proposed to prevent the development of metabolic
syndrome. These include increased physical activity (such as walking 30 minutes
every day), and eating healthy food that is low in fat. There are many researches
that support the value of a healthy lifestyle as above. But keeping up with such
life style is difficult for many people, that is why we decided to do research in one
of the life style modifications that does not require physical activity. This is called
non exercise activity thermogenesis (NEAT). We will use this lifestyle
intervention on high risk Qatari individuals with components of metabolic
syndrome.
i-Purpose of the research:

The purpose of this study is to examine the effect of non exercise activity
thermogenesis (NEAT) in reducing the following metabolic syndrome markers; 1weight 2- waist circumference 3- hip circumference 4- triglycerides level. These
markers will also be used to establish high risk criteria.
2-Selection of research subjects:

You will be invited to participate in this research if you are over i8 years old and
you have A and 2 out of 5 of the following criteria:
A) Elevated waist circumference of 102 cm or above (men) and 88 cm or above
(women)
B) Fasting blood sugar over 5.6 mmol/L
C) Blood pressure over or equal 130/85 mmHg
D) Triglycerides above or equal 1.7 mmol/L
E) HDL cholesterol lower than 1.o3mmol/L (men) and 1.29 mmol/L ( women)
3-Distinction between routine care and research activities:

Your participation in this research is completely voluntary; you will continue your
treatment with your doctor as usual. Should you choose to participate in this
research; you will be advised on ways to modify your diet and life style. For
example, you will be advised to do some activities that you were not doing before
like parking your car away instead of close to the entrance, standing instead of
sitting for long time, moving your legs and arms as much as you can during the
day and other such non-exercise activities. You may or may not benefit from this
life style modification, but previous research have shown benefit from these
changes.
4-Explanation of the procedures:

The tool "NEAT" that we will use in this research is defined as all other
movements outside of exercise such as walking, talking, toe tapping, guitar
playing, dancing or shopping. Researchers found that obese move 2.5 hours less
per day than lean people. This equates to 350 calories expended per day. What all
this means is that society as a whole needs to be moving move and spend less
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time sitting around at the office, watching TV etc. If you watch TV you only burn
5 calories an hour above your metabolic rate. After 4 hours of sitting and
watching TV you have only burned 20 calories.
5-The risks and discomfort involved:

You will spend more time in doing more of the Non Exercise Activities than
sitting. There is no risk for you and no discomfort. You may feel better.
6-The Safety precautions in this research:

There are no safety precautions
7-The benefits of the study:

You may or may not benefit from this research. If you benefited from this
research, you may be able to lose weight, which may result in better control of
blood sugar, high blood pressure, and blood fat levels.
8-The alternative procedures or treatments for this research:

If you decide not to participate in this research, you can continue the same
treatment that you are already on.
9-The options to remain on the research treatment after termination
of the research:

Your participation in this research is expected to last for one year. After one year,
we encourage that you continue these activities on your own.
10-Details of the person to contact in case of Injury or enquiry during
the research:

Dr. Samer Hammoudeh 7007642 -5546316
ii-Details of the financial or other compensatior which might be
provided to the research participants if any:

We will not provide money for your participation in this research.
12-Duration of the research:

If you participate in this research, you will be asked to come for a hospital visit at
6 and at 12 months after your enrollment. You will receive by mail reminders to
these NEAT exercises and visits.
13-Where the research is going to be conducted:

The research will be conducted at your home. You will be assessed in the
outpatient clinic on the day of your appointment.
14-Assurance of anonymity and confidentiality:

Total privacy cannot be guaranteed. We will protect your privacy to the extent
permitted by law. All research data will be stored in a password protected
computer. If the results from this research are published, your name will not be
made public. The following may look at your research and medical records: The
research team or persons authorized by the research team; the research
committee member's if/when they choose to.
15-Non-coercive disclaimer:

There is no pressure on you to participate in the study; you are free to choose any
of the treatment modalities offered and that there will be no pressure on you to
continue in the study even after enrollment. You are free to withdraw from this
research at any time, and this decision will not and in any way affect the medical
care you are entitled to.
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16-Option to withdraw from the study without penalty:
You can withdraw at any time from the study even after enrollment in the
research without any penalty.
17-Details about termination of the study:
The study will continue for one year for the participant. At the end of the study
you may continue these activities as part of your learned life style modification
activities. •
I.
-18-Instances in which there might be inoimplete disclosure of
information: None
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APPENDIX F: APPROVAL LETTER FROM HAMAD
HOSPITAL

a.\ 1 h II � a .., ..,�

HAMAD MEDICAL CORPORATION

Medical R�scarch Centre
& Research Committee
Tel: 4392440/Fax: 4395402
Ref. No: RC/1092/2010
Date: 31" January20 I 0

Prof. Abdulbari Bener
Consultant & Head
Department of Epidemiology & Medical Statistics
Dear Prof. Bcner
Research Protocol #9181/09:-The effect of "Non exercise activity
thermogeneis (NEAT) "on weight loss among Qatari subjects with
metabolic syndrome in a randomized clinical trial.
Reference is made to the above Research Protocol submitted for review and
approval from the Research Committee.
On behalf of the Research Committee, it is to inform you that the above
Research Proposal meets up with the ethical requirements of the Hamad
Medical Corporation and approval is granted for one year from 3 I st January
2010.
Signed Infonned Consent should be taken from each participant. One copy
of the consent should be handed over to the participant and the second copy
should be kept with Principal Investigator whereas the third copy of the
same should be kept in su�ject's Medical Record.
Progress report of the study should be submitted bi-annually and final rep011
upon completion to Medical Research Centre.
We wish vou all success and await the result in due course.
Yomssi \
�
Dr. Rajvir gh
Coordinator, Research Committee
Cc:
1) Dr. Samcr Hammoudeh, DDS, MPH, Dr. PH Student, Loma Linda
University, USA
2) Dr. Mahmoud Zirie, Head of the Department of Endocrinology
3) Dr. Abdullah Al-Hamaq, President of Diabetes Association, Qatar
Foundation

P.O. Box: 3050 DOHA· QATAR· Tel.: 4392222 • '.393333 ·Fax: 4411133 i ! I I ,n- ,..,..SLl - t nnn - ! i'l1'n"I": ::.,� - _,...J..i - ;,__,,,, .,JI -1' •: · �--�
(961505i
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APPENDIX G: APPROVAL LETTER FROM LLU IRB

•
�

LOMA LINDA
UNNERSJTI'

INSTITUTIONAL REVIEW BOARD

SPONSORED RESEARCH • 11 t 88 Anderson Street • Loma Unda, CA 92350
(909) 558-4531 {voice)• (909) 558-0131 {fax)

Initial Approval Notice - Expedited

/RB# 5110341

Tonstad, Serena
To:
Department: Health Promotion & Education
Protocol: The effect of non-exercise activity thermogenesis on subjects with metabolic syndrome
This study was reviewed and approved administratively on behalf of the IRB. This decision includes the following determinations:
Risk to research subjects: Minimal
Approval period begins: 01-Mar-2012 and ends 28-Feb-2013
Stipulations of approval: Research intervention is unde IRB approved by Hamad Medical Corp.
Consent Form

Unless IRB has given a specific waiver of informed consent (as documented in the approval stipulations above) the IRS-approved and
stamped consent form accompanies this letter. This now becomes the official master consent form for making copies to provide to
study participants.
Adverse Events I Protocol Changes

The IRB should be notified in writing of any modifications to the approved research protocol. Adverse effects must be reported to the
I RB in accordance with institutional policy. If sponsor or contractual adverse event reporting requirements differ from requirements for
reporting to IRB, all reporting requirements must still be met.

Protocol Review

Your protocol is tentatively scheduled for review and renewal at least two weeks prior to the approval end-date indicated above. To
assure uninterrupted approval of this project, you will be sent a report form to request renewal by completing and timely returning to
Office of Sponsored Research. Anticipate the approval expiration so your study does not lapse; contact /RB for assistance if
necessary. In addition to reporting the requested renewal status information, you may also use the form to close the study at that time,
if applicable.
Records

All records relating to this project, including signed consent forms, must be kept on file for three years following completion of the

s�1

Please note the Pl's name and the IRB number assigned to this IRB protocol (as indicated above) on any future communications
with the IRB. Direct all communications to the IRB c/o the Office of Sponsored Research.
Thank you for your cooperation in LLU's shared responsibility for the ethical use of human subjects in research.

Loma Linda University Adventist Health Sciences Center holds Fedcralwide Assurance (FWA) No. 6447 with the U.S. Office for Human Research Protections. and the !RB
registration no. is t0RG226. This Assurance applies to the following institutions: Loma Linda University, Loma Linda University Medical Center (including Loma Linda
Unr,ersity Children's Hospital, LLU Community Medical Center), Loma Linda University Behavioral Medicine. and affiliated medical practices groups.
IRS Chair:
Rhodes L. Rigsby, /A.O.
Deparjment of Medicine
(909) 558-2341, rrigsby@llu.edu

/RB Administrator:
Linda G. Halsread. M.A., Director
Sponsored Research
Ext 43570, Fax 80131, lhals/ead@//u.cdv
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/RB Specialist:
Marl( Testerman
Sponsored Research
Ext 43042, Fax 80131, mlesterman@llu.edu

